https://trial.medpath.com/news/ucsf-and-samsung-launch-ambitious-1000-subject-remote-trial-to-map-brain-aging-through-wearable-technology 2026-07-09T20:13:04+00:00 hourly 0.9 https://trial.medpath.com/news/menopause-s-silent-symptoms-online-forums-reveal-cognitive-and-emotional-burden-missing-from-clinical-records 2026-07-09T20:11:23+00:00 hourly 0.9 https://trial.medpath.com/news/forte-biosciences-fb102-demonstrates-statistically-significant-efficacy-in-phase-1b-vitiligo-trial 2026-07-09T20:10:25+00:00 hourly 0.9 https://trial.medpath.com/news/ge-healthcare-and-mayo-clinic-launch-mi-bet-study-to-personalize-radioligand-therapy-in-advanced-prostate-cancer 2026-07-09T19:09:23+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-agonists-show-promise-in-reducing-pulmonary-fibrosis-from-long-covid-in-diabetic-patients-mouse-study-finds 2026-07-09T19:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/teleoperated-humanoid-robots-complete-first-ever-live-surgeries-in-preclinical-trial 2026-07-09T18:35:00+00:00 hourly 0.9 https://trial.medpath.com/news/rectal-spacers-show-acceptable-safety-in-locally-advanced-prostate-cancer-radiotherapy 2026-07-09T18:34:00+00:00 hourly 0.9 https://trial.medpath.com/news/macrophage-metabolic-reprogramming-emerges-as-a-key-driver-of-chronic-transplant-rejection-and-a-new-therapeutic-target 2026-07-09T18:26:00+00:00 hourly 0.9 https://trial.medpath.com/news/rybodyn-awarded-1-3m-dow-grant-to-advance-novel-antibody-therapies-against-cryptic-lung-cancer-targets 2026-07-09T18:10:08+00:00 hourly 0.9 https://trial.medpath.com/news/ireland-launches-health-referral-scheme-for-first-time-personal-drug-possession-offenders 2026-07-09T18:10:06+00:00 hourly 0.9 https://trial.medpath.com/news/southeast-asia-oncology-drug-access-market-to-reach-4-41-billion-by-2031-driven-by-biosimilar-adoption-and-precision-oncology 2026-07-09T17:08:40+00:00 hourly 0.9 https://trial.medpath.com/news/b-cell-depletion-therapy-market-projected-to-reach-usd-62-6-billion-by-2036-driven-by-autoimmune-disease-demand 2026-07-09T17:08:29+00:00 hourly 0.9 https://trial.medpath.com/news/dndi-and-serum-institute-of-india-partner-to-launch-global-phase-iii-trial-for-dengue-monoclonal-antibody 2026-07-09T17:08:25+00:00 hourly 0.9 https://trial.medpath.com/news/cystic-fibrosis-market-poised-for-transformation-as-cftr-modulators-gene-therapy-and-precision-medicine-drive-growth-through-2035 2026-07-09T17:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/quantum-annealing-boosts-drug-like-molecule-generation-beyond-training-data-d-wave-and-shionogi-study-shows 2026-07-09T17:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/aging-cells-shift-preference-toward-short-genes-revealing-new-anti-aging-therapeutic-targets 2026-07-09T17:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/greenland-shark-s-dna-repair-mechanism-may-hold-key-to-preserving-human-vision 2026-07-09T16:19:00+00:00 hourly 0.9 https://trial.medpath.com/news/arpa-h-launches-160-million-thrive-program-to-advance-custom-gene-editing-for-rare-diseases 2026-07-09T16:09:02+00:00 hourly 0.9 https://trial.medpath.com/news/prime-medicine-advances-toward-clinical-milestones-following-patent-dispute-resolution 2026-07-09T16:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/arpa-h-thrive-awards-73-4-million-to-advance-personalized-gene-editing-platforms-for-rare-pediatric-diseases 2026-07-09T16:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/china-s-818-decree-draws-100-submissions-as-greater-bay-area-builds-integrated-clinical-research-ecosystem 2026-07-09T15:05:58+00:00 hourly 0.9 https://trial.medpath.com/news/roche-discontinues-two-huntington-s-disease-programs-after-tominersen-fails-phase-ii-and-rg6496-hits-preclinical-safety-hurdle 2026-07-09T14:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/godavari-biorefineries-secures-european-patent-for-novel-anti-cancer-drug-composition-with-enhanced-bioavailability 2026-07-09T14:06:39+00:00 hourly 0.9 https://trial.medpath.com/news/adlai-nortye-advances-first-in-class-pan-ras-on-adc-an4035-into-phase-i-trial-for-ras-addicted-solid-tumors 2026-07-09T14:06:29+00:00 hourly 0.9 https://trial.medpath.com/news/blue-earth-therapeutics-doses-first-patient-in-phase-1-trial-of-alpha-emitting-psma-radiopharmaceutical-for-mcrpc 2026-07-09T14:06:27+00:00 hourly 0.9 https://trial.medpath.com/news/small-molecule-api-market-to-reach-370-36-billion-by-2035-driven-by-oncology-demand-and-manufacturing-innovation 2026-07-09T13:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-q2-earnings-beat-drives-institutional-accumulation-as-pipeline-readouts-loom 2026-07-09T13:06:48+00:00 hourly 0.9 https://trial.medpath.com/news/bispecific-antibodies-face-a-manufacturing-bottleneck-as-drug-pipelines-surge 2026-07-09T13:06:47+00:00 hourly 0.9 https://trial.medpath.com/news/retinal-reserve-framework-functional-testing-and-systemic-biomarkers-enable-personalized-proactive-retinal-care 2026-07-09T13:06:13+00:00 hourly 0.9 https://trial.medpath.com/news/il-1-immune-pathway-identified-as-critical-defense-against-fatal-candida-albicans-infections 2026-07-09T12:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/axxam-and-heartbeat-bio-forge-strategic-partnership-to-advance-human-relevant-cardiovascular-drug-discovery 2026-07-09T12:07:36+00:00 hourly 0.9 https://trial.medpath.com/news/easo-efad-and-ecpo-issue-landmark-consensus-nutritional-and-psychological-support-essential-for-glp-1-obesity-treatment-success 2026-07-09T09:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/astrazeneca-s-wainua-falls-short-in-phase-iii-attr-cm-study-despite-positive-subgroup-signal 2026-07-09T09:06:35+00:00 hourly 0.9 https://trial.medpath.com/news/dysport-becomes-first-botulinum-toxin-to-achieve-positive-phase-iii-results-in-both-episodic-and-chronic-migraine 2026-07-09T07:08:46+00:00 hourly 0.9 https://trial.medpath.com/news/nationwide-survey-finds-only-one-third-of-spanish-microbiology-labs-perform-quantitative-hbsag-testing 2026-07-09T06:33:00+00:00 hourly 0.9 https://trial.medpath.com/news/environmental-bacteria-act-as-stealth-reservoirs-for-instant-extreme-antibiotic-resistance-in-lung-infections 2026-07-09T06:30:00+00:00 hourly 0.9 https://trial.medpath.com/news/new-german-expert-consensus-provides-first-risk-based-recommendations-for-snpwt-use-in-closed-surgical-incisions 2026-07-09T06:25:00+00:00 hourly 0.9 https://trial.medpath.com/news/rfk-jr-s-hhs-moves-to-create-covid-19-vaccine-injury-table-raising-scientific-scrutiny-concerns 2026-07-09T04:14:19+00:00 hourly 0.9 https://trial.medpath.com/news/ascendis-pharma-reports-positive-transcon-cnp-clinical-data-amid-revenue-growth-to-720-million 2026-07-09T02:56:33+00:00 hourly 0.9 https://trial.medpath.com/news/antihistamines-and-colchicine-show-modest-short-term-benefit-for-long-covid-fatigue-in-landmark-uk-trial 2026-07-09T00:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/sarcopenia-emerges-as-a-modifiable-prognostic-factor-in-breast-cancer-driving-calls-for-standardized-screening-and-multimodal-intervention 2026-07-09T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/multistate-salmonella-outbreak-linked-to-cage-free-eggs-escalated-to-fda-class-i-recall 2026-07-08T23:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/parental-stress-drives-increased-screen-time-in-young-children-study-finds 2026-07-08T23:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/ohsu-board-votes-to-transition-primate-research-center-toward-nonanimal-human-based-methods 2026-07-08T23:07:30+00:00 hourly 0.9 https://trial.medpath.com/news/abeona-therapeutics-advances-commercial-rollout-of-zevaskyn-cell-therapy-amid-strong-analyst-support 2026-07-08T21:09:57+00:00 hourly 0.9 https://trial.medpath.com/news/fda-moves-to-eliminate-adequate-provision-rule-threatening-broadcast-pharma-advertising 2026-07-08T21:09:41+00:00 hourly 0.9 https://trial.medpath.com/news/bridgebio-pharma-s-1-billion-equity-raise-fuels-pipeline-momentum-amid-regulatory-progress 2026-07-08T20:13:54+00:00 hourly 0.9 https://trial.medpath.com/news/gleneagles-hospital-chennai-achieves-complete-remission-in-rare-brain-lymphoma-using-india-s-indigenous-car-t-therapy-nexcar19 2026-07-08T20:13:31+00:00 hourly 0.9 https://trial.medpath.com/news/diet-microbiome-synergy-drives-immunotherapy-efficacy-in-obesity-landmark-nature-study-reveals 2026-07-08T20:13:30+00:00 hourly 0.9 https://trial.medpath.com/news/consumer-reports-investigation-finds-concerning-arsenic-levels-across-all-52-rice-products-tested 2026-07-08T20:13:19+00:00 hourly 0.9 https://trial.medpath.com/news/altruist-biologics-hangzhou-adc-facility-receives-first-trilateral-provincial-regulatory-approval-for-segmented-manufacturing 2026-07-08T20:11:44+00:00 hourly 0.9 https://trial.medpath.com/news/lsu-and-fmol-health-award-1-6m-to-seven-research-teams-targeting-louisiana-s-critical-health-challenges 2026-07-08T20:11:39+00:00 hourly 0.9 https://trial.medpath.com/news/immune-surveillance-and-evasion-of-senescent-cells-new-therapeutic-frontiers-in-cancer-and-aging 2026-07-08T20:02:00+00:00 hourly 0.9 https://trial.medpath.com/news/hypoxia-therapy-dramatically-extends-lifespan-in-mouse-model-of-htra2-linked-mitochondrial-disease 2026-07-08T19:10:35+00:00 hourly 0.9 https://trial.medpath.com/news/nfl-players-face-fourfold-higher-neurodegenerative-mortality-in-largest-ever-cohort-study 2026-07-08T19:10:01+00:00 hourly 0.9 https://trial.medpath.com/news/aws-graphrag-deployment-cuts-drug-research-cycles-by-87-compressing-six-month-screening-to-three-weeks 2026-07-08T19:09:31+00:00 hourly 0.9 https://trial.medpath.com/news/dea-proposes-permanent-schedule-i-ban-for-tianeptine-the-original-gas-station-heroin 2026-07-08T19:08:52+00:00 hourly 0.9 https://trial.medpath.com/news/crispr-koala-reveals-81-hidden-genetic-drivers-of-triple-negative-breast-cancer-in-living-tumors 2026-07-08T18:26:00+00:00 hourly 0.9 https://trial.medpath.com/news/asco-issues-new-guidelines-for-systemic-thyroid-cancer-therapy-amid-rapid-molecular-advances 2026-07-08T18:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/abbvie-s-elahere-shows-positive-phase-2-data-in-ovarian-cancer-strengthening-oncology-pipeline 2026-07-08T18:07:28+00:00 hourly 0.9 https://trial.medpath.com/news/fda-classifies-lupin-s-prednisolone-acetate-eye-drops-recall-as-class-ii-over-foreign-particulate-contamination 2026-07-08T17:06:27+00:00 hourly 0.9 https://trial.medpath.com/news/enlife-research-raises-6-crore-seed-funding-to-develop-ai-powered-blood-test-for-early-alzheimer-s-detection 2026-07-08T16:12:09+00:00 hourly 0.9 https://trial.medpath.com/news/dea-moves-to-temporarily-ban-synthetic-kratom-compound-7-oh-classifying-it-as-schedule-i 2026-07-08T16:11:59+00:00 hourly 0.9 https://trial.medpath.com/news/allotera-therapeutics-closes-35-million-financing-bringing-total-to-150-million-for-pivotal-stage-off-the-shelf-car-t-therapy-in-t-cell-cancers 2026-07-08T16:11:29+00:00 hourly 0.9 https://trial.medpath.com/news/lung-transplant-achieves-100-one-year-survival-in-select-patients-with-terminal-lung-limited-nsclc-landmark-dream-registry-study-shows 2026-07-08T16:09:04+00:00 hourly 0.9 https://trial.medpath.com/news/china-s-pharma-industry-charts-innovation-driven-future-at-landmark-beijing-conference 2026-07-08T16:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/porton-advanced-s-uc-mscs-cell-bank-for-exosome-manufacturing-receives-u-s-fda-drug-master-file-acceptance 2026-07-08T15:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/prime-medicine-wins-arbitration-against-beam-therapeutics-over-gene-editing-therapy-for-aatd 2026-07-08T15:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/former-merck-and-nasa-leaders-join-spacemd-to-accelerate-space-based-pharmaceutical-r-d 2026-07-08T15:07:06+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-bifidobacterium-shows-dual-promise-oral-vaccine-boosts-anti-tumor-immunity-in-phase-i-trial-as-nci-funds-systemic-delivery-platform-for-pancreatic-cancer 2026-07-08T15:06:28+00:00 hourly 0.9 https://trial.medpath.com/news/spectrum-science-appoints-industry-veteran-marie-emms-as-president-of-clinical-business 2026-07-08T15:06:14+00:00 hourly 0.9 https://trial.medpath.com/news/vaccinex-to-present-new-biomarker-data-supporting-expanded-phase-2b-trial-of-pepinemab-in-early-alzheimer-s-disease 2026-07-08T15:06:09+00:00 hourly 0.9 https://trial.medpath.com/news/cancer-s-dark-proteome-emerges-as-a-new-frontier-for-drug-targets-and-immunotherapy 2026-07-08T15:06:05+00:00 hourly 0.9 https://trial.medpath.com/news/tardive-dyskinesia-market-projected-to-reach-usd-4-4-billion-by-2036-growing-at-8-1-cagr-amid-pipeline-innovation 2026-07-08T14:31:00+00:00 hourly 0.9 https://trial.medpath.com/news/moderna-reshuffles-board-with-ex-biogen-cfo-michael-mcdonnell-amid-950m-patent-settlement-and-eu-rsv-supply-deal 2026-07-08T14:07:24+00:00 hourly 0.9 https://trial.medpath.com/news/new-international-guideline-published-for-diagnosing-and-treating-allan-herndon-dudley-syndrome 2026-07-08T14:07:02+00:00 hourly 0.9 https://trial.medpath.com/news/oman-moves-closer-to-adopting-national-biotechnology-strategy 2026-07-08T14:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/niagen-bioscience-launches-nb4168-a-proprietary-nad-precursor-as-first-pharmaceutical-candidate-for-ataxia-telangiectasia 2026-07-08T14:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/nautilus-biotechnology-to-report-second-quarter-2026-financial-results-on-july-28 2026-07-08T14:06:45+00:00 hourly 0.9 https://trial.medpath.com/news/global-hotspots-where-breast-cancer-and-atrial-fibrillation-overlap-reveal-smoking-and-alcohol-as-shared-modifiable-risk-factors 2026-07-08T13:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/nsf-launches-project-triad-to-integrate-quantum-sensing-networking-and-computing-for-real-world-applications-including-precision-medicine 2026-07-08T13:07:32+00:00 hourly 0.9 https://trial.medpath.com/news/xiaflex-meets-phase-iii-primary-endpoint-in-plantar-fibromatosis-setting-stage-for-first-ever-fda-approval 2026-07-08T13:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-rmat-designation-to-emmecell-s-eo2002-cell-therapy-for-corneal-edema 2026-07-08T13:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/chemomab-and-scipher-medicine-merge-to-advance-nebokitug-in-ai-powered-phase-2-rheumatoid-arthritis-trial 2026-07-08T13:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/the-ai-trust-gap-in-pharma-r-d-why-scientists-are-hesitating-and-what-must-change 2026-07-08T13:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/u-of-t-and-mcmaster-anchor-40-million-genesys-university-seed-fund-to-retain-canadian-life-sciences-innovation 2026-07-08T13:07:02+00:00 hourly 0.9 https://trial.medpath.com/news/restart-life-sciences-reports-146-sequential-revenue-growth-and-details-next-generation-product-pipeline 2026-07-08T13:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/sheffield-students-produce-life-changing-rare-disease-guides-for-families-worldwide 2026-07-08T13:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/mindrank-secures-52m-series-b-to-advance-ai-native-drug-r-d-engine-and-oral-glp-1-agonist-mdr-001-into-phase-iii 2026-07-08T13:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/okyo-pharma-accelerates-urcosimod-into-global-phase-3-pivotal-trial-for-neuropathic-corneal-pain-following-fda-alignment 2026-07-08T12:09:30+00:00 hourly 0.9 https://trial.medpath.com/news/defence-therapeutics-appoints-dr-ryan-simms-as-coo-and-head-of-radiopharmaceutical-programs 2026-07-08T11:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/non-invasive-brush-biopsy-test-detects-oral-squamous-cell-carcinoma-with-95-5-accuracy-in-under-one-hour 2026-07-08T11:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/asia-s-longevity-economy-boom-luxury-clinics-surge-amid-scientific-scrutiny-and-policy-gaps 2026-07-08T10:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/governed-hybrid-model-emerges-as-the-next-competitive-frontier-in-clinical-research-site-strategy 2026-07-08T10:07:39+00:00 hourly 0.9 https://trial.medpath.com/news/ai-can-calculate-medical-probabilities-but-it-cannot-answer-the-question-that-matters-most 2026-07-08T10:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/genespire-and-sr-tiget-demonstrate-durable-preclinical-efficacy-of-liver-directed-gene-therapy-for-methylmalonic-acidemia 2026-07-08T09:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/ai-orchestration-not-more-outreach-is-key-to-fixing-healthcare-s-patient-access-problem 2026-07-08T07:09:04+00:00 hourly 0.9 https://trial.medpath.com/news/bio-rad-launches-vericheck-ddpcr-kit-portfolio-for-cell-and-gene-therapy-quality-control-on-qx700-platform 2026-07-08T07:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/catholic-health-and-hiccc-at-nyp-columbia-partner-to-expand-cancer-clinical-trial-access-across-long-island 2026-07-08T07:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/kuehnle-agrosystems-closes-series-b-financing-to-commercialise-world-first-dark-fermentation-natural-astaxanthin 2026-07-08T07:07:36+00:00 hourly 0.9 https://trial.medpath.com/news/coregen-receives-fda-clearance-for-first-in-human-trial-of-crg-150-a-novel-adoptive-cell-therapy-targeting-src-3-in-multiple-solid-tumors 2026-07-08T06:09:32+00:00 hourly 0.9 https://trial.medpath.com/news/bma-warns-ps16-7-million-cut-to-medical-academic-funding-threatens-uk-research-innovation-and-nhs-resilience 2026-07-08T06:09:00+00:00 hourly 0.9 https://trial.medpath.com/news/australian-tga-issues-updated-safety-warning-on-ashwagandha-and-very-rare-risk-of-liver-injury 2026-07-08T03:09:02+00:00 hourly 0.9 https://trial.medpath.com/news/brain-cell-changes-reveal-why-parkinson-s-disease-affects-more-men-than-women 2026-07-08T02:55:00+00:00 hourly 0.9 https://trial.medpath.com/news/gvhd-pipeline-2026-cell-based-microbiome-and-targeted-therapies-reshape-treatment-landscape 2026-07-08T01:07:13+00:00 hourly 0.9 https://trial.medpath.com/news/novo-nordisk-enters-agreement-with-vivani-medical-to-evaluate-ultra-long-acting-semaglutide-implant-for-chronic-weight-management 2026-07-08T01:07:08+00:00 hourly 0.9 https://trial.medpath.com/news/ai-reveals-previously-invisible-cortical-lesions-on-conventional-mri-scans-transforming-ms-research-and-clinical-care 2026-07-08T00:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/spear-bio-to-unveil-first-commercially-available-singleplex-emtbr-tau-immunoassay-and-novel-ptau-217-assay-at-aaic-2026 2026-07-08T00:07:41+00:00 hourly 0.9 https://trial.medpath.com/news/ubc-faculty-of-medicine-researchers-awarded-over-5-8m-in-nserc-discovery-grants-for-biomedical-innovation 2026-07-08T00:07:21+00:00 hourly 0.9 https://trial.medpath.com/news/plasma-nfl-and-gfap-fail-as-biomarkers-in-myasthenia-gravis-controlled-study-finds 2026-07-08T00:07:10+00:00 hourly 0.9 https://trial.medpath.com/news/novel-antibody-drug-conjugate-eliminates-residual-cancer-cells-in-majority-of-patients-with-b-cell-all 2026-07-08T00:07:02+00:00 hourly 0.9 https://trial.medpath.com/news/healome-therapeutics-raises-ps2-million-seed-funding-to-advance-eye-drop-matrix-platform-for-ocular-surface-diseases 2026-07-07T22:10:35+00:00 hourly 0.9 https://trial.medpath.com/news/clinuvel-announces-strategic-restructure-and-us-relocation-to-unlock-pipeline-value-led-by-vitiligo-program 2026-07-07T22:10:20+00:00 hourly 0.9 https://trial.medpath.com/news/vanda-pharmaceuticals-secures-fda-rare-pediatric-disease-designation-for-antisense-oligonucleotide-therapy-vca-894a-in-cmt2s 2026-07-07T22:10:18+00:00 hourly 0.9 https://trial.medpath.com/news/altasciences-and-evidence-matters-achieve-ai-breakthrough-in-nonclinical-drug-development-automation 2026-07-07T22:10:14+00:00 hourly 0.9 https://trial.medpath.com/news/new-study-advances-dry-mrna-vaccine-patch-design-offering-path-beyond-cold-chain-storage 2026-07-07T22:10:13+00:00 hourly 0.9 https://trial.medpath.com/news/men-face-significantly-higher-risk-of-late-stage-cancer-diagnosis-across-20-solid-tumor-types-nci-study-finds 2026-07-07T22:10:12+00:00 hourly 0.9 https://trial.medpath.com/news/the-ethics-of-being-left-out-of-health-research-when-over-protection-becomes-exclusion 2026-07-07T22:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/manganese-ferrite-nanoparticles-generate-57-more-heating-power-than-cobalt-ferrite-in-magnetic-hyperthermia-cancer-research 2026-07-07T20:09:54+00:00 hourly 0.9 https://trial.medpath.com/news/legionnaires-disease-outbreak-in-manhattan-s-upper-east-side-23-cases-confirmed-health-officials-urge-early-detection 2026-07-07T20:09:42+00:00 hourly 0.9 https://trial.medpath.com/news/discount-or-validation-the-shifting-economics-of-western-pharma-s-licensing-of-chinese-assets 2026-07-07T20:09:13+00:00 hourly 0.9 https://trial.medpath.com/news/southern-nevada-s-bioscience-ecosystem-gains-global-attention-at-bio-international-convention-2026 2026-07-07T20:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/missing-rna-tests-skew-hepatitis-c-cure-rates-nationwide-u-s-cohort-study-finds 2026-07-07T19:11:27+00:00 hourly 0.9 https://trial.medpath.com/news/life-sciences-tools-services-q1-2026-earnings-illumina-bruker-lead-as-10x-genomics-revenue-declines 2026-07-07T19:10:07+00:00 hourly 0.9 https://trial.medpath.com/news/university-of-wyoming-inbre-program-receives-18-9m-nih-grant-to-bolster-biomedical-research-and-education 2026-07-07T19:10:04+00:00 hourly 0.9 https://trial.medpath.com/news/galidesivir-cleared-for-compassionate-use-against-bundibugyo-ebola-in-uganda 2026-07-07T18:09:54+00:00 hourly 0.9 https://trial.medpath.com/news/mount-sinai-launches-7-2m-nih-funded-center-to-advance-personalized-peanut-allergy-treatments 2026-07-07T18:08:28+00:00 hourly 0.9 https://trial.medpath.com/news/phthalate-exposure-during-pregnancy-linked-to-shorter-gestation-and-lower-birth-weight-in-large-us-cohort 2026-07-07T17:12:39+00:00 hourly 0.9 https://trial.medpath.com/news/pmv-pharmaceuticals-advances-p53-targeted-precision-oncology-pipeline 2026-07-07T17:12:08+00:00 hourly 0.9 https://trial.medpath.com/news/mild-sleep-deprivation-leads-to-measurable-weight-gain-columbia-study-finds 2026-07-07T17:12:04+00:00 hourly 0.9 https://trial.medpath.com/news/inaugural-aacr-d3-conference-convenes-leaders-across-oncology-drug-development-to-catalyze-innovation 2026-07-07T17:12:03+00:00 hourly 0.9 https://trial.medpath.com/news/protagonist-therapeutics-rallies-on-rusfertide-nda-acceptance-and-icotyde-fda-approval 2026-07-07T17:11:59+00:00 hourly 0.9 https://trial.medpath.com/news/ccran-and-signal49-research-launch-phase-ii-initiative-to-make-comprehensive-genomic-profiling-a-standard-of-care-for-metastatic-cancer-in-canada 2026-07-07T17:09:24+00:00 hourly 0.9 https://trial.medpath.com/news/samhsa-unveils-281-million-in-moud-grants-while-restricting-harm-reduction-and-mandating-psychosocial-services 2026-07-07T17:08:52+00:00 hourly 0.9 https://trial.medpath.com/news/serum-reg3a-emerges-as-promising-blood-based-biomarker-for-ulcerative-colitis-disease-monitoring 2026-07-07T17:08:45+00:00 hourly 0.9 https://trial.medpath.com/news/splashbio-launches-as-independent-platform-company-to-tackle-alzheimer-s-trial-screen-failures-with-biomarker-driven-pre-screening 2026-07-07T17:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/radiotherapy-reprograms-immune-response-in-cutaneous-t-cell-lymphoma-revealing-new-biomarkers-for-recurrence 2026-07-07T16:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/cu-anschutz-researchers-develop-nonhormonal-therapy-targeting-root-cause-of-genitourinary-syndrome-of-menopause 2026-07-07T16:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/eha-2026-lifetime-achievement-awardee-claire-harrison-reflects-on-jak-inhibitors-and-the-future-of-myeloproliferative-neoplasms 2026-07-07T16:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/hetero-launches-once-weekly-semaglutide-truglyx-in-kenya-as-novo-nordisk-brings-ozempic-and-wegovy-to-market 2026-07-07T15:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-announces-322-layoffs-at-east-hanover-facility-triggering-warn-act-investigation 2026-07-07T15:08:23+00:00 hourly 0.9 https://trial.medpath.com/news/gut-microbiome-changes-can-signal-future-type-2-diabetes-risk-years-before-diagnosis-large-swedish-study-finds 2026-07-07T15:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/cyllene-therapeutics-raises-eur33m-series-c-to-advance-hsv-1-gene-therapy-for-neurogenic-bladder-conditions 2026-07-07T15:08:15+00:00 hourly 0.9 https://trial.medpath.com/news/bayer-forms-first-ever-academic-medical-center-clinical-trials-alliance-with-cu-anschutz-uchealth-and-children-s-hospital-colorado 2026-07-07T15:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/saol-therapeutics-resubmits-nda-for-sl1009-dca-in-pyruvate-dehydrogenase-complex-deficiency-following-fda-alignment 2026-07-07T15:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/teva-to-advance-anti-il-15-antibody-tev-408-into-phase-2b-for-vitiligo-following-promising-phase-1b-results 2026-07-07T14:06:47+00:00 hourly 0.9 https://trial.medpath.com/news/point-of-care-molecular-testing-nearly-doubles-appropriate-treatment-for-vaginitis-randomized-trial-shows 2026-07-07T14:06:13+00:00 hourly 0.9 https://trial.medpath.com/news/the-craft-curation-model-independent-small-batch-cultivators-reshape-new-jersey-s-cannabis-market 2026-07-07T13:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/vitalant-reports-critical-type-o-blood-shortage-at-two-year-low-urges-immediate-donations 2026-07-07T12:11:54+00:00 hourly 0.9 https://trial.medpath.com/news/china-s-cde-launches-pioneer-program-formally-integrating-organoids-and-organ-on-a-chip-into-drug-regulatory-evaluation 2026-07-07T12:11:41+00:00 hourly 0.9 https://trial.medpath.com/news/rio-trial-long-acting-bnabs-3bnc117-ls-and-10-1074-ls-delay-hiv-rebound-and-accelerate-reservoir-decay-after-treatment-interruption 2026-07-07T12:11:35+00:00 hourly 0.9 https://trial.medpath.com/news/tiximed-initiates-phase-1b-mad-study-of-oral-txnip-inhibitor-tix100-for-type-1-diabetes 2026-07-07T11:06:20+00:00 hourly 0.9 https://trial.medpath.com/news/insurers-pocket-copay-assistance-funds-meant-to-defray-patient-drug-costs-leaving-patients-financially-devastated 2026-07-07T10:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/measurable-residual-disease-as-surrogate-endpoint-in-cll-trials-methodological-concerns-raised-over-meta-analysis-findings 2026-07-07T10:08:25+00:00 hourly 0.9 https://trial.medpath.com/news/exosome-drug-delivery-services-market-poised-to-reach-24-33-billion-by-2035-growing-at-17-5-cagr 2026-07-07T10:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/lsu-vet-med-launches-2026-summer-scholars-program-with-17-veterinary-students-pursuing-biomedical-research 2026-07-07T09:08:52+00:00 hourly 0.9 https://trial.medpath.com/news/roche-to-present-new-trontinemab-long-term-data-and-preventron-phase-iii-trial-design-at-aaic-2026 2026-07-07T09:08:13+00:00 hourly 0.9 https://trial.medpath.com/news/uk-government-issues-supply-warnings-for-nifedipine-and-oxcarbazepine-amid-multiple-brand-shortages 2026-07-07T09:08:12+00:00 hourly 0.9 https://trial.medpath.com/news/trial-supports-glargine-use-in-resource-limited-type-1-diabetes-care-with-benefits-emerging-at-12-months 2026-07-07T04:07:53+00:00 hourly 0.9 https://trial.medpath.com/news/huayuan-smartgene-secures-tens-of-millions-rmb-seed-round-to-advance-ai-powered-virtual-cell-platform-for-human-drug-efficacy-prediction 2026-07-07T03:08:17+00:00 hourly 0.9 https://trial.medpath.com/news/aureka-releases-opendde-an-open-source-ai-drug-discovery-engine-with-655m-parameters-for-antibody-antigen-co-folding 2026-07-07T03:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/nhs-unveils-eight-new-minimum-standards-to-overhaul-patient-communications-and-end-appointment-notification-failures 2026-07-07T03:06:57+00:00 hourly 0.9 https://trial.medpath.com/news/from-4-to-94-survival-how-st-jude-total-therapy-clinical-trials-transformed-pediatric-all-outcomes 2026-07-07T00:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/amo-pharma-secures-fda-mhra-and-health-canada-alignment-on-registrational-trial-design-for-amo-02-in-congenital-myotonic-dystrophy-type-1 2026-07-06T23:08:09+00:00 hourly 0.9 https://trial.medpath.com/news/precision-biotics-market-poised-to-reach-17-46-billion-by-2035-driven-by-microbiome-science-and-ai-powered-discovery 2026-07-06T23:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/wakemed-atrium-health-merger-faces-mounting-opposition-over-cost-and-charity-care-concerns 2026-07-06T22:50:00+00:00 hourly 0.9 https://trial.medpath.com/news/rxsight-announces-preliminary-q2-2026-results-alcon-collaboration-and-next-generation-light-adjustable-iol-pipeline 2026-07-06T22:08:15+00:00 hourly 0.9 https://trial.medpath.com/news/radiopharmaceutical-plus-car-t-therapy-converts-immune-resistant-solid-tumors-into-treatable-targets-in-neuroblastoma-models 2026-07-06T22:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/alberta-cancer-foundation-invests-35-million-to-power-cancer-clinical-trials-across-the-province 2026-07-06T21:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/neoadjuvant-lenvatinib-shrinks-thyroid-tumor-and-improves-surgical-outcomes-in-advanced-thyroid-cancer 2026-07-06T20:10:38+00:00 hourly 0.9 https://trial.medpath.com/news/whiddon-college-of-medicine-names-2026-dean-s-predoctoral-fellowship-awardees-for-cancer-and-infectious-disease-research 2026-07-06T20:10:12+00:00 hourly 0.9 https://trial.medpath.com/news/cleveland-researchers-identify-15-pgdh-as-promising-drug-target-for-parkinson-s-disease 2026-07-06T19:10:30+00:00 hourly 0.9 https://trial.medpath.com/news/twelve-years-after-pharmagate-south-africa-s-patent-reform-stalemate-leaves-lifesaving-medicines-out-of-reach 2026-07-06T19:09:50+00:00 hourly 0.9 https://trial.medpath.com/news/bradley-maron-named-editor-in-chief-of-circulation-bringing-precision-medicine-and-pulmonary-vascular-expertise 2026-07-06T19:09:42+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-car-like-tregs-suppress-allergic-asthma-in-mice-offering-blueprint-for-novel-allergy-immunotherapy 2026-07-06T18:11:06+00:00 hourly 0.9 https://trial.medpath.com/news/drug-resistant-shigella-spreads-as-sexually-transmitted-infection-across-england-genomic-study-reveals 2026-07-06T18:10:43+00:00 hourly 0.9 https://trial.medpath.com/news/oncology-must-confront-hidden-side-effects-of-breakthrough-cancer-therapies 2026-07-06T18:10:11+00:00 hourly 0.9 https://trial.medpath.com/news/northwestern-chemists-solve-30-year-rye-pollen-mystery-opening-new-avenues-for-cancer-drug-discovery 2026-07-06T18:09:02+00:00 hourly 0.9 https://trial.medpath.com/news/india-selects-first-biotech-startups-under-1-trillion-r-d-initiative-as-transparency-concerns-linger 2026-07-06T17:09:32+00:00 hourly 0.9 https://trial.medpath.com/news/top-10-research-priorities-published-to-shape-the-future-of-uk-childhood-food-allergy-research 2026-07-06T17:09:31+00:00 hourly 0.9 https://trial.medpath.com/news/biomarker-guided-antidepressant-selection-boosts-response-rates-by-67-in-precision-psychiatry-trial 2026-07-06T17:09:30+00:00 hourly 0.9 https://trial.medpath.com/news/transgenic-animal-model-market-poised-to-reach-6-79-billion-by-2035-driven-by-crispr-and-precision-medicine 2026-07-06T17:09:05+00:00 hourly 0.9 https://trial.medpath.com/news/fast-walking-pace-in-80s-linked-to-50-lower-risk-of-cognitive-decline-study-finds 2026-07-06T17:08:13+00:00 hourly 0.9 https://trial.medpath.com/news/disruption-of-de-novo-fatty-acid-biosynthesis-rewires-cellular-lipid-metabolism-toward-mtor-signaling 2026-07-06T17:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/beyond-boston-regional-biotech-hubs-attract-billions-in-manufacturing-investment 2026-07-06T17:07:17+00:00 hourly 0.9 https://trial.medpath.com/news/nebius-expands-ai-discovery-awards-with-new-medical-tracks-awards-1-4-million-to-healthcare-ai-innovators 2026-07-06T16:11:31+00:00 hourly 0.9 https://trial.medpath.com/news/northwell-health-appoints-brian-s-kim-as-first-chief-biotechnology-officer-to-accelerate-bioelectronic-medicine-commercialization 2026-07-06T16:10:59+00:00 hourly 0.9 https://trial.medpath.com/news/french-orthopedic-pioneer-movmedix-enters-u-s-market-following-fda-510-k-clearance-of-lars-r-acj-synthetic-ligament-system 2026-07-06T16:10:36+00:00 hourly 0.9 https://trial.medpath.com/news/splash-beverage-group-acquires-exclusive-global-rights-to-cannepil-for-drug-resistant-epilepsy 2026-07-06T16:10:34+00:00 hourly 0.9 https://trial.medpath.com/news/genentech-triples-lobbying-spend-to-1-81m-as-medicare-drug-price-negotiations-intensify 2026-07-06T16:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/brain-organoid-research-on-the-iss-advances-toward-new-treatments-for-rett-syndrome-and-other-neurological-disorders 2026-07-06T16:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/persistent-disparities-in-cancer-screening-found-among-sexual-and-gender-minority-populations 2026-07-06T16:07:54+00:00 hourly 0.9 https://trial.medpath.com/news/vivos-receives-fda-ide-approval-for-first-in-human-radiogel-trial-in-non-resectable-papillary-thyroid-carcinoma 2026-07-06T15:10:24+00:00 hourly 0.9 https://trial.medpath.com/news/xaira-therapeutics-expands-leadership-team-to-advance-ai-driven-drug-discovery-pipeline 2026-07-06T15:10:22+00:00 hourly 0.9 https://trial.medpath.com/news/taiwan-prosecutors-investigate-central-union-oil-over-carcinogen-tainted-soybean-oil-scandal 2026-07-06T15:09:54+00:00 hourly 0.9 https://trial.medpath.com/news/uc-san-diego-launches-institute-for-applied-health-intelligence-to-bridge-the-last-mile-of-ai-driven-care-delivery 2026-07-06T15:09:02+00:00 hourly 0.9 https://trial.medpath.com/news/immunotherapy-and-summer-sun-essential-skin-safety-guidance-for-cancer-patients 2026-07-06T15:09:01+00:00 hourly 0.9 https://trial.medpath.com/news/dx-vx-advances-global-out-licensing-talks-for-first-in-class-oral-obesity-drug-and-cancer-vaccine-at-bio-2026 2026-07-06T14:08:16+00:00 hourly 0.9 https://trial.medpath.com/news/ionis-completes-enrollment-in-pivotal-cohort-of-phase-3-reveal-study-for-obudanersen-in-angelman-syndrome 2026-07-06T13:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/alzheon-to-present-new-evidence-of-neurovascular-protection-and-preserved-brain-microstructure-from-oral-valiltramiprosate-trials-in-apoe4-4-alzheimer-s-patients-at-aaic-2026 2026-07-06T13:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/revolver-therapeutics-secures-ps572k-to-target-undruggable-transcription-factors-in-colorectal-cancer 2026-07-06T13:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/domina-tablet-compression-platform-wins-the-medicine-maker-innovation-awards-2025-grand-prize 2026-07-06T13:07:46+00:00 hourly 0.9 https://trial.medpath.com/news/biomarker-guided-antidepressant-selection-boosts-response-rates-by-nearly-67-in-precision-psychiatry-trial 2026-07-06T13:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/immuron-engages-pullan-consulting-to-secure-partner-for-imm-529-a-novel-oral-polyclonal-antibody-for-clostridioides-difficile-infection 2026-07-06T13:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/rebuilding-the-u-s-biomedical-innovation-engine-the-case-for-sustained-federal-research-investment 2026-07-06T12:08:56+00:00 hourly 0.9 https://trial.medpath.com/news/pet-imaging-reveals-tau-related-brain-pattern-in-living-huntington-s-disease-patients-for-the-first-time 2026-07-06T12:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/eight-irish-health-tech-startups-shortlisted-for-2026-kpmg-global-tech-innovator-competition 2026-07-06T11:09:29+00:00 hourly 0.9 https://trial.medpath.com/news/contact-lens-import-compliance-in-2026-a-10-country-regulatory-map 2026-07-06T11:09:07+00:00 hourly 0.9 https://trial.medpath.com/news/lonza-upgrades-2026-margin-outlook-as-h1-performance-surges-across-all-business-platforms 2026-07-06T09:10:25+00:00 hourly 0.9 https://trial.medpath.com/news/curifylabs-secures-eur12-million-series-a-to-expand-3d-printed-personalised-medicine-platform-across-the-u-s 2026-07-06T09:10:16+00:00 hourly 0.9 https://trial.medpath.com/news/teclistamab-shows-rapid-efficacy-in-two-patients-with-autoimmune-neuropathy-in-landmark-compassionate-use-report 2026-07-06T09:09:37+00:00 hourly 0.9 https://trial.medpath.com/news/repronovo-doses-first-participant-in-eu-phase-2-nordic-trial-of-oral-oxytocin-receptor-antagonist-rpn-002-for-embryo-implantation 2026-07-06T09:08:39+00:00 hourly 0.9 https://trial.medpath.com/news/nanomedicine-pioneer-cheon-jin-woo-named-korea-s-top-scientist-of-2026-for-magnetogenetics-and-neural-circuit-breakthroughs 2026-07-06T09:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/astex-and-genentech-enter-490m-collaboration-to-target-cell-cycle-regulator-in-breast-cancer 2026-07-06T09:07:41+00:00 hourly 0.9 https://trial.medpath.com/news/the-biosimilar-race-apac-s-factory-to-the-world-confronts-the-value-trap 2026-07-06T08:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-to-acquire-myricx-bio-for-up-to-1-5-billion-securing-next-generation-nmti-adc-platform-for-solid-tumours 2026-07-06T06:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/hawaii-s-first-early-phase-cancer-clinical-research-center-opens-at-uh-cancer-center 2026-07-06T04:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/dolly-the-sheep-at-30-how-a-cloned-ewe-paved-the-way-for-stem-cell-therapies-and-gene-edited-animals 2026-07-06T02:08:43+00:00 hourly 0.9 https://trial.medpath.com/news/uterine-aging-may-reduce-donor-egg-pregnancy-success-after-age-49-landmark-study-finds 2026-07-06T00:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/the-dark-side-of-the-brazilian-butt-lift-boom-uk-s-underregulated-aesthetics-industry-under-scrutiny 2026-07-06T00:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/pd-l1-pet-ct-imaging-tracks-atezolizumab-target-saturation-in-tumours-british-journal-of-cancer-study-reports 2026-07-05T23:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/base-edited-car-t-cell-therapy-achieves-durable-remissions-in-pediatric-t-all-nejm-reports-9-of-11-patients-in-remission 2026-07-05T23:07:36+00:00 hourly 0.9 https://trial.medpath.com/news/microbiota-dependent-enterocyte-oxytocin-signaling-emerges-as-a-mechanistic-link-in-autism-spectrum-disorder 2026-07-05T22:10:36+00:00 hourly 0.9 https://trial.medpath.com/news/ai-will-not-replace-doctors-but-doctors-using-ai-will-replace-those-who-don-t-says-aig-hospitals-chairman 2026-07-05T21:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/biohacker-bryan-johnson-diagnosed-with-autoimmune-gastritis-plans-experimental-treatment-approach 2026-07-05T19:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/vivebiotech-and-zelluna-advance-off-the-shelf-tcr-nk-cell-therapy-for-solid-tumors-toward-2026-clinical-trials 2026-07-05T19:08:33+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-discover-the-deep-sleep-circuit-that-builds-muscle-burns-fat-and-boosts-the-brain 2026-07-05T18:10:52+00:00 hourly 0.9 https://trial.medpath.com/news/olean-general-hospital-reopens-renovated-mildred-milliman-radiation-medicine-center-with-4-1-million-upgrade-and-varian-truebeam-linac 2026-07-05T18:09:47+00:00 hourly 0.9 https://trial.medpath.com/news/xelios-biometrics-advances-single-medical-record-system-using-fingerprint-identification-in-madrid-hospitals 2026-07-05T18:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/plasma-5-hiaa-emerges-as-a-high-accuracy-biomarker-for-major-depressive-disorder 2026-07-05T17:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/saas-adoption-in-clinical-trials-reshapes-access-compliance-and-competitive-dynamics 2026-07-05T17:06:48+00:00 hourly 0.9 https://trial.medpath.com/news/gut-microbiome-shifts-linked-to-alzheimer-s-biomarkers-before-symptoms-appear 2026-07-05T15:06:38+00:00 hourly 0.9 https://trial.medpath.com/news/taiwan-escalates-etomidate-to-category-1-narcotic-as-drug-impaired-driving-cases-surge 2026-07-05T13:06:21+00:00 hourly 0.9 https://trial.medpath.com/news/australian-government-warns-doctors-over-ai-scribing-tools-as-privacy-and-safety-concerns-grow 2026-07-05T11:04:00+00:00 hourly 0.9 https://trial.medpath.com/news/advocacy-group-urges-india-to-revise-essential-medicines-list-as-17-cancer-drugs-and-9-monoclonal-antibodies-remain-excluded 2026-07-05T07:10:15+00:00 hourly 0.9 https://trial.medpath.com/news/indian-researchers-develop-indigenous-placenta-on-chip-platform-to-transform-pregnancy-research 2026-07-05T07:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/flavonoid-rich-foods-linked-to-15-lower-breast-cancer-risk-even-in-women-with-high-genetic-susceptibility 2026-07-05T07:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/analysts-maintain-bullish-stance-on-hutchmed-china-with-buy-ratings-and-price-targets-above-hk-32 2026-07-05T04:07:16+00:00 hourly 0.9 https://trial.medpath.com/news/proteogenomic-analysis-refines-medulloblastoma-into-seven-molecular-subtypes-revealing-new-therapeutic-targets 2026-07-05T04:06:51+00:00 hourly 0.9 https://trial.medpath.com/news/intermittent-fasting-may-offer-an-easier-path-to-weight-loss-than-calorie-counting-study-finds 2026-07-05T02:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/dr-reddy-s-secures-us-fda-approval-for-rituximab-biosimilar-fresenius-kabi-to-commercialize 2026-07-05T02:08:35+00:00 hourly 0.9 https://trial.medpath.com/news/ibm-ceo-quantum-computing-to-deliver-measurable-revenue-by-2028-2029-trillion-dollar-value-by-end-of-2030s 2026-07-05T00:08:58+00:00 hourly 0.9 https://trial.medpath.com/news/jingze-bio-files-third-hkex-ipo-application-spotlighting-biosimilar-competition-in-china-s-fertility-and-ophthalmology-markets 2026-07-04T22:07:18+00:00 hourly 0.9 https://trial.medpath.com/news/vagus-nerve-stimulation-produces-durable-improvements-in-severe-treatment-resistant-depression-recover-trial-shows 2026-07-04T22:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/morgan-stanley-upgrades-charles-river-laboratories-to-overweight-citing-biopharma-funding-rebound-and-ai-driven-discovery-tailwinds 2026-07-04T21:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/nsw-government-imposes-tough-new-restrictions-on-nitrous-oxide-sales-to-curb-rising-abuse-and-neurological-harm 2026-07-04T21:06:57+00:00 hourly 0.9 https://trial.medpath.com/news/neutrophil-extracellular-traps-emerge-as-organ-specific-drivers-and-therapeutic-targets-in-ischaemia-reperfusion-injury 2026-07-04T19:07:36+00:00 hourly 0.9 https://trial.medpath.com/news/phase-i-glutapanc-trial-l-glutamine-plus-gemcitabine-nab-paclitaxel-shows-promising-efficacy-in-advanced-pancreatic-cancer 2026-07-04T19:07:26+00:00 hourly 0.9 https://trial.medpath.com/news/greek-cancer-patients-still-awaiting-biomarker-testing-access-eight-months-after-reform 2026-07-04T19:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/xtrackers-msci-world-biotechnology-ucits-etf-shows-strong-bullish-signals-across-all-time-horizons 2026-07-04T19:07:21+00:00 hourly 0.9 https://trial.medpath.com/news/wave-life-sciences-advances-precision-genetic-medicines-pipeline-targeting-neurological-and-rare-diseases 2026-07-04T18:10:14+00:00 hourly 0.9 https://trial.medpath.com/news/taiwan-fda-launches-food-safety-overhaul-after-benzopyrene-contamination-scandal-at-central-union-oil 2026-07-04T18:10:13+00:00 hourly 0.9 https://trial.medpath.com/news/florida-sues-prime-therapeutics-and-express-scripts-for-alleged-drug-price-fixing 2026-07-04T18:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-call-for-global-moratorium-on-mirror-life-as-doomsday-clock-factors-in-synthetic-biology-threat 2026-07-04T18:09:24+00:00 hourly 0.9 https://trial.medpath.com/news/zydus-and-apollo-hospitals-partner-to-launch-shield-multi-cancer-detection-blood-test-in-india 2026-07-04T18:07:18+00:00 hourly 0.9 https://trial.medpath.com/news/il-6-modifies-coronary-artery-disease-risk-associated-with-elevated-lipoprotein-a-uk-biobank-study-finds 2026-07-04T18:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/reprogramming-macrophage-immunometabolism-via-glutamine-antagonism-potentiates-anti-tumor-immunity 2026-07-04T17:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/immunome-director-s-4-39-million-stock-sale-executed-under-pre-planned-rule-10b5-1-trading-plan-amid-pipeline-momentum 2026-07-04T17:07:38+00:00 hourly 0.9 https://trial.medpath.com/news/sanyou-bio-and-baiyunshan-xihe-forge-strategic-alliance-to-accelerate-ai-driven-radiopharmaceutical-development 2026-07-04T17:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/india-needs-national-strategy-to-bridge-gap-between-cancer-innovation-and-patient-access-experts-urge 2026-07-04T17:06:41+00:00 hourly 0.9 https://trial.medpath.com/news/proton-pump-inhibitors-linked-to-reduced-durvalumab-benefit-in-stage-iii-nsclc-post-hoc-analysis-of-pacific-trial 2026-07-04T16:08:25+00:00 hourly 0.9 https://trial.medpath.com/news/india-calls-for-mission-mode-action-as-liver-disease-and-type-2-diabetes-surge-among-younger-populations 2026-07-04T16:07:39+00:00 hourly 0.9 https://trial.medpath.com/news/global-colon-cancer-association-to-host-webinar-on-her2-positive-colorectal-cancer-and-biomarker-testing-for-patient-advocates 2026-07-04T16:07:28+00:00 hourly 0.9 https://trial.medpath.com/news/oligodendrocyte-nrf2-deficiency-drives-myelin-pathology-in-age-related-cognitive-decline 2026-07-04T15:07:45+00:00 hourly 0.9 https://trial.medpath.com/news/shilpa-medicare-and-orion-corporation-partner-to-co-develop-nivolumab-biosimilar-for-european-market 2026-07-04T15:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/updated-abcs-framework-gives-clinicians-a-clearer-path-to-prevent-cardiovascular-disease 2026-07-04T14:09:27+00:00 hourly 0.9 https://trial.medpath.com/news/cost-efficient-long-read-trio-barcoded-adaptive-sequencing-improves-rare-disease-diagnosis 2026-07-04T14:08:31+00:00 hourly 0.9 https://trial.medpath.com/news/guernsey-launches-island-based-cancer-trial-partnership-enabling-blood-cancer-patients-to-contribute-to-uk-research-without-travel 2026-07-04T14:08:12+00:00 hourly 0.9 https://trial.medpath.com/news/supreme-court-of-canada-affirms-methods-of-medical-treatment-are-unpatentable-upholds-janssen-s-invega-sustenna-dosing-patent 2026-07-04T10:09:38+00:00 hourly 0.9 https://trial.medpath.com/news/lung-tumors-hijack-sensory-neurons-via-pge2-to-drive-cancer-cachexia-study-reveals 2026-07-04T05:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/research-tools-consumables-q1-earnings-waters-corporation-leads-with-91-5-revenue-growth 2026-07-04T04:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/invasive-fungal-infections-market-poised-for-robust-growth-by-2036-as-novel-broad-spectrum-antifungals-advance-through-pipeline 2026-07-04T02:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/tenwek-hospital-recruits-consultant-specialists-and-leadership-roles-across-multiple-departments 2026-07-04T01:06:05+00:00 hourly 0.9 https://trial.medpath.com/news/building-the-foundation-for-healthcare-ai-why-infrastructure-not-algorithms-determines-clinical-success 2026-07-04T01:06:04+00:00 hourly 0.9 https://trial.medpath.com/news/pakistan-and-china-forge-pharmaceutical-cooperation-under-cpec-2-0-at-landmark-b2b-investment-conference 2026-07-04T00:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/family-raises-ps100000-for-dfmo-access-to-prevent-neuroblastoma-relapse-in-two-year-old-uk-girl 2026-07-04T00:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/organ-on-a-chip-technology-bridges-the-gap-in-patient-derived-precision-medicine 2026-07-03T23:08:44+00:00 hourly 0.9 https://trial.medpath.com/news/sensor-based-digital-therapeutics-devices-market-to-reach-590-9-million-by-2036-driven-by-regulatory-pathways-and-payer-coverage 2026-07-03T23:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/rituximab-market-poised-for-sustained-growth-through-2034-driven-by-multi-indication-use-and-biosimilar-expansion 2026-07-03T22:08:38+00:00 hourly 0.9 https://trial.medpath.com/news/amway-india-launches-phase-ii-of-power-of-5-school-nutrition-programme-in-new-delhi-targeting-15000-beneficiaries 2026-07-03T22:08:08+00:00 hourly 0.9 https://trial.medpath.com/news/nk-cell-pioneer-eric-vivier-to-receive-2026-william-b-coley-award-and-deliver-inaugural-lecture-at-sitc-annual-meeting 2026-07-03T22:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/duke-engineers-grow-retinal-blood-vessel-cells-from-ipscs-restoring-vision-in-mouse-models 2026-07-03T21:10:46+00:00 hourly 0.9 https://trial.medpath.com/news/experimental-radiation-missile-radiopharmaceutical-therapy-offers-hope-to-children-with-treatment-resistant-cancers 2026-07-03T21:10:23+00:00 hourly 0.9 https://trial.medpath.com/news/global-cosmetovigilance-market-to-reach-22-04-billion-by-2035-as-regulatory-demands-reshape-cosmetic-safety-monitoring 2026-07-03T21:09:04+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-ennumo-as-eighth-pegfilgrastim-biosimilar-expanding-oncology-supportive-care-options 2026-07-03T21:08:25+00:00 hourly 0.9 https://trial.medpath.com/news/extreme-heat-kills-more-americans-than-hurricanes-yet-federal-disaster-law-has-never-applied 2026-07-03T20:15:00+00:00 hourly 0.9 https://trial.medpath.com/news/ivonescimab-outperforms-keytruda-in-head-to-head-phase-iii-trial-signaling-china-s-biotech-ascent-from-the-greater-bay-area 2026-07-03T20:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/multnomah-county-replaces-deflection-center-operator-as-program-struggles-with-low-utilization 2026-07-03T20:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/xtalks-announces-life-science-webinar-calendar-for-july-and-august-2026-highlighting-precision-oncology-alzheimer-s-research-and-ai-driven-clinical-trials 2026-07-03T19:08:52+00:00 hourly 0.9 https://trial.medpath.com/news/oncodaily-medical-journal-expands-editorial-board-with-20-oncology-specialists-across-12-countries 2026-07-03T19:08:48+00:00 hourly 0.9 https://trial.medpath.com/news/fda-steps-up-import-enforcement-on-infant-formula-cantaloupes-and-seafood 2026-07-03T19:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/international-biotechnology-trust-declares-second-interim-dividend-of-15-67-pence-per-share 2026-07-03T18:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/edding-genor-doses-first-patient-in-phase-ib-ii-trial-of-trispecific-pd-1-ctla-4-vegf-antibody-gb268-in-metastatic-breast-cancer 2026-07-03T17:11:45+00:00 hourly 0.9 https://trial.medpath.com/news/fda-probes-sevoflurane-linked-neurological-complications-in-patients-of-venezuelan-ancestry 2026-07-03T17:11:44+00:00 hourly 0.9 https://trial.medpath.com/news/proton-project-nominated-for-science-breakthrough-of-the-year-2026-for-novel-anti-virulence-agent-against-s-aureus 2026-07-03T17:11:43+00:00 hourly 0.9 https://trial.medpath.com/news/fungal-prime-editing-platform-fpe7max-unlocks-silent-gene-clusters-yields-three-novel-anti-cancer-lead-compounds 2026-07-03T17:11:42+00:00 hourly 0.9 https://trial.medpath.com/news/german-dairy-group-ehrmann-partners-with-glow25-to-launch-rtd-collagen-coffees 2026-07-03T17:09:50+00:00 hourly 0.9 https://trial.medpath.com/news/european-biotech-act-advances-as-council-agrees-negotiating-mandate-on-gmm-and-organ-processing-reforms 2026-07-03T17:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/coffee-consumption-linked-to-significant-reductions-in-cirrhosis-liver-cancer-and-liver-related-death-in-large-uk-biobank-study 2026-07-03T17:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/proteinguide-a-unified-framework-for-property-guided-protein-sequence-design 2026-07-03T17:07:36+00:00 hourly 0.9 https://trial.medpath.com/news/combined-newborn-screening-for-sma-and-scid-in-italy-achieves-100-positive-predictive-value-over-five-years 2026-07-03T17:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/wa-researchers-secure-6-1-million-to-advance-paediatric-cancer-immunotherapy-neuromuscular-disease-genetics-and-health-equity 2026-07-03T17:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/ohio-state-lands-4-million-nsf-grant-to-build-national-quantum-sensing-testbed-for-biomedical-diagnostics 2026-07-03T16:08:43+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-ennumotm-pegfilgrastim-pccg-accord-biopharma-s-second-pegfilgrastim-biosimilar-to-neulasta 2026-07-03T16:08:39+00:00 hourly 0.9 https://trial.medpath.com/news/dea-moves-to-classify-synthetic-7-oh-as-schedule-i-amid-rising-deaths-and-hospitalizations 2026-07-03T16:07:39+00:00 hourly 0.9 https://trial.medpath.com/news/penn-medicine-launches-first-then-first-now-campaign-celebrating-275-years-of-medical-innovation 2026-07-03T16:06:51+00:00 hourly 0.9 https://trial.medpath.com/news/rethinking-bladder-cancer-hidden-biology-multi-scale-networks-and-counterintuitive-therapeutic-strategies 2026-07-03T14:09:06+00:00 hourly 0.9 https://trial.medpath.com/news/harvard-s-compass-model-predicts-immunotherapy-response-across-cancers-with-concept-bottleneck-transformer 2026-07-03T13:08:58+00:00 hourly 0.9 https://trial.medpath.com/news/uk-cardiovascular-clinical-trials-market-projected-to-reach-usd-892-2-million-by-2033-driven-by-nhs-data-infrastructure-and-rising-disease-burden 2026-07-03T13:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/multi-omics-study-reveals-proteogenomic-signature-of-high-risk-diffuse-large-b-cell-lymphoma 2026-07-03T13:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/bioinnovation-institute-backs-six-startups-with-eur7-8m-to-bridge-europe-s-translational-gap 2026-07-03T13:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/tumor-microenvironment-modulation-market-projected-to-reach-usd-3-73-billion-by-2031-growing-at-7-4-cagr 2026-07-03T10:09:37+00:00 hourly 0.9 https://trial.medpath.com/news/biomaterial-based-strategies-reshape-gout-therapy-from-nanoparticles-to-microneedles 2026-07-03T10:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/global-antidiabetic-drugs-market-projected-to-reach-usd-309-84-billion-by-2035-driven-by-glp-1-and-sglt2-innovation 2026-07-03T10:09:32+00:00 hourly 0.9 https://trial.medpath.com/news/global-trop-2-targeted-therapy-market-projected-to-reach-3-29-billion-by-2031-driven-by-adc-innovation-and-rising-cancer-prevalence 2026-07-03T10:09:31+00:00 hourly 0.9 https://trial.medpath.com/news/sky-labs-unveils-ring-type-cuffless-blood-pressure-monitor-cart-bp-pro-for-drug-clinical-trials-at-basel-summit 2026-07-03T10:09:26+00:00 hourly 0.9 https://trial.medpath.com/news/global-microbiome-oncology-market-projected-to-reach-1-94-billion-by-2031-growing-at-40-7-cagr 2026-07-03T10:09:22+00:00 hourly 0.9 https://trial.medpath.com/news/global-cancer-biologics-market-projected-to-reach-189-billion-by-2035-driven-by-antibody-dominance-and-precision-medicine 2026-07-03T09:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/gene-editing-therapeutics-market-poised-for-12-5-cagr-growth-driven-by-crispr-dominance-and-oncology-applications 2026-07-03T09:09:08+00:00 hourly 0.9 https://trial.medpath.com/news/uq-researchers-develop-first-drug-targeting-elusive-c5ar2-receptor-paving-path-to-transform-mnd-into-a-manageable-chronic-condition 2026-07-03T09:09:07+00:00 hourly 0.9 https://trial.medpath.com/news/the-vein-to-vein-problem-can-apac-s-cold-chain-carry-advanced-therapies 2026-07-03T09:08:38+00:00 hourly 0.9 https://trial.medpath.com/news/symeres-and-axxam-appoint-russell-thomas-as-joint-cso-to-unify-integrated-drug-discovery-platform 2026-07-03T08:08:46+00:00 hourly 0.9 https://trial.medpath.com/news/alibaba-to-pay-600-million-to-settle-doj-probe-into-illegal-pharmaceutical-sales-on-its-platforms 2026-07-03T07:09:56+00:00 hourly 0.9 https://trial.medpath.com/news/new-early-phase-cancer-clinical-trials-unit-opens-at-royal-north-shore-hospital-in-sydney 2026-07-03T07:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/fda-s-ai-integration-faces-leadership-uncertainty-after-high-level-departures 2026-07-03T05:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/asbmb-names-five-recipients-of-2026-science-outreach-and-communication-grants 2026-07-03T05:07:54+00:00 hourly 0.9 https://trial.medpath.com/news/cdsco-panel-rejects-abbvie-s-clinical-trial-waiver-for-parkinson-s-drug-mandates-phase-iii-study-in-india 2026-07-03T04:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/agilent-launches-ai-powered-xcelligence-rtca-esight-ai-module-for-label-free-live-cell-imaging-analysis 2026-07-03T04:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/fda-expands-casgevy-approval-to-children-ages-2-nashville-hospital-treats-first-commercial-patient 2026-07-03T04:07:10+00:00 hourly 0.9 https://trial.medpath.com/news/gravity-activates-mitochondrial-translation-space-station-study-reveals-molecular-pathway-linking-mechanical-forces-to-cellular-energy-production 2026-07-03T02:12:06+00:00 hourly 0.9 https://trial.medpath.com/news/ai-designed-wrap-proteins-solve-decades-old-membrane-protein-solubility-problem-opening-door-to-syphilis-vaccine 2026-07-03T02:11:16+00:00 hourly 0.9 https://trial.medpath.com/news/rentschler-biopharma-appoints-former-bachem-cco-torsten-wohr-as-ceo-to-lead-next-growth-phase 2026-07-03T02:11:15+00:00 hourly 0.9 https://trial.medpath.com/news/fda-authorizes-zyn-nicotine-pouches-to-carry-modified-risk-claim-as-safer-alternative-to-cigarettes 2026-07-03T02:11:11+00:00 hourly 0.9 https://trial.medpath.com/news/advances-in-targeting-il-1-family-cytokines-for-inflammatory-disease-treatment 2026-07-03T02:09:16+00:00 hourly 0.9 https://trial.medpath.com/news/norovirus-outbreak-on-ruby-princess-sickens-125-during-alaska-cruise-from-san-francisco 2026-07-02T23:42:00+00:00 hourly 0.9 https://trial.medpath.com/news/bcg-immunotherapy-reprograms-cns-immunity-and-alters-amyloid-dynamics-in-older-adults 2026-07-02T23:09:28+00:00 hourly 0.9 https://trial.medpath.com/news/federal-youth-online-safety-bills-advance-raising-compliance-challenges-for-cannabis-advertising 2026-07-02T22:09:49+00:00 hourly 0.9 https://trial.medpath.com/news/x-cell-derived-antibody-shows-potential-to-reverse-type-1-diabetes-in-preclinical-models 2026-07-02T22:09:44+00:00 hourly 0.9 https://trial.medpath.com/news/vivani-medical-to-spin-out-neurostimulation-subsidiary-cortigent-via-merger-with-nasdaq-listed-clearone 2026-07-02T21:12:18+00:00 hourly 0.9 https://trial.medpath.com/news/single-cell-proteomics-reveals-hidden-cardiomyocyte-diversity-reshaping-precision-medicine-and-drug-development 2026-07-02T21:11:31+00:00 hourly 0.9 https://trial.medpath.com/news/nutraveri-launches-deterministic-ai-readiness-score-for-supplement-founders-replacing-black-box-models-with-auditable-regulatory-intelligence 2026-07-02T21:10:24+00:00 hourly 0.9 https://trial.medpath.com/news/sitting-for-more-than-30-minutes-at-a-time-linked-to-higher-cancer-death-risk-large-uk-biobank-study-finds 2026-07-02T21:09:28+00:00 hourly 0.9 https://trial.medpath.com/news/usc-scientists-target-cpla2-enzyme-to-halt-brain-inflammation-in-apoe4-carriers-backed-by-3-million-pattiz-foundation-gift 2026-07-02T21:09:24+00:00 hourly 0.9 https://trial.medpath.com/news/vamorolone-demonstrates-glucocorticoid-activity-without-clinically-meaningful-immunosuppression-in-phase-i-study 2026-07-02T21:09:20+00:00 hourly 0.9 https://trial.medpath.com/news/eight-hour-eating-window-sustains-long-term-weight-loss-one-year-follow-up-study-shows 2026-07-02T21:08:50+00:00 hourly 0.9 https://trial.medpath.com/news/ucl-and-eisai-extend-neurodegenerative-disease-drug-discovery-partnership-through-2030 2026-07-02T20:09:16+00:00 hourly 0.9 https://trial.medpath.com/news/h5n1-bird-flu-detected-in-new-zealand-for-the-first-time-as-australia-braces-for-poultry-impact 2026-07-02T20:09:11+00:00 hourly 0.9 https://trial.medpath.com/news/from-infectious-devastation-to-chronic-disease-how-250-years-of-american-medicine-transformed-mortality 2026-07-02T20:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/biomarker-guided-drug-combinations-may-overcome-treatment-resistance-in-advanced-melanoma 2026-07-02T19:10:41+00:00 hourly 0.9 https://trial.medpath.com/news/macrophage-like-cells-emerge-as-dynamic-biomarker-for-tracking-diabetic-macular-edema-treatment-response 2026-07-02T19:10:40+00:00 hourly 0.9 https://trial.medpath.com/news/resorantel-a-dual-targeting-therapeutic-with-potent-efficacy-against-staphylococcus-aureus 2026-07-02T19:10:33+00:00 hourly 0.9 https://trial.medpath.com/news/india-amends-drugs-rules-to-bring-cell-and-gene-therapies-under-centralized-regulatory-oversight 2026-07-02T19:10:28+00:00 hourly 0.9 https://trial.medpath.com/news/major-investment-launches-precision-health-platform-in-western-sweden-to-accelerate-personalised-medicine 2026-07-02T19:10:22+00:00 hourly 0.9 https://trial.medpath.com/news/first-in-class-car-t-therapy-gcar1-shows-early-promise-against-treatment-resistant-solid-tumors 2026-07-02T19:10:20+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-markers-spop-and-chd1-identified-as-key-determinants-of-ferroptosis-sensitivity-in-advanced-prostate-cancer 2026-07-02T19:10:19+00:00 hourly 0.9 https://trial.medpath.com/news/gea-invests-eur4-million-in-sarstedt-biotechnology-center-to-bridge-lab-to-industrial-scale-up-gap 2026-07-02T19:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/cannabix-technologies-expands-breath-based-drug-testing-platform-to-detect-methamphetamine-and-amphetamine 2026-07-02T19:09:15+00:00 hourly 0.9 https://trial.medpath.com/news/explainable-ai-model-predicts-immunotherapy-outcomes-in-metastatic-renal-cell-carcinoma-the-meet-uro-15-ai-study 2026-07-02T19:09:13+00:00 hourly 0.9 https://trial.medpath.com/news/umass-memorial-nurses-overwhelmingly-authorize-14-day-strike-amid-staffing-and-safety-concerns 2026-07-02T19:08:58+00:00 hourly 0.9 https://trial.medpath.com/news/cms-proposes-340b-payment-cuts-and-site-neutral-imaging-payments-in-2027-opps-rule 2026-07-02T18:10:54+00:00 hourly 0.9 https://trial.medpath.com/news/spinogenix-appoints-harvard-neuroscience-leaders-to-scientific-advisory-board-as-synaptic-regenerative-therapy-advances 2026-07-02T18:10:46+00:00 hourly 0.9 https://trial.medpath.com/news/patient-engagement-emerges-as-the-rate-limiting-step-in-clinical-trial-participation 2026-07-02T18:09:26+00:00 hourly 0.9 https://trial.medpath.com/news/cleveland-clinic-s-new-neurological-assessment-center-to-transform-routine-data-capture-into-clinical-research-goldmine 2026-07-02T18:09:24+00:00 hourly 0.9 https://trial.medpath.com/news/three-health-systems-compete-for-225-acute-care-beds-in-new-hanover-county-north-carolina 2026-07-02T17:10:22+00:00 hourly 0.9 https://trial.medpath.com/news/retinal-vasculitis-signals-emerge-across-intravitreal-anti-vegf-and-complement-inhibitor-therapies 2026-07-02T17:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/arima-genomics-partners-with-active-motif-to-distribute-hi-c-research-kits-sharpening-focus-on-clinical-cancer-diagnostics 2026-07-02T16:30:00+00:00 hourly 0.9 https://trial.medpath.com/news/astrazeneca-and-cspc-pharma-expand-partnership-with-1-77-billion-sirna-deal-for-kidney-diseases 2026-07-02T16:11:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-advisory-committee-briefing-documents-cast-doubt-on-capricor-s-deramiocel-for-duchenne-muscular-dystrophy-shares-plunge-60 2026-07-02T16:10:49+00:00 hourly 0.9 https://trial.medpath.com/news/r-opra-launches-full-cycle-production-of-abbvie-s-paricalcitol-generic-dekalpar-for-chronic-kidney-disease-in-moscow 2026-07-02T16:10:47+00:00 hourly 0.9 https://trial.medpath.com/news/culture-media-and-trust-shape-gmo-acceptance-in-nigeria-study-finds 2026-07-02T16:10:41+00:00 hourly 0.9 https://trial.medpath.com/news/chronic-sinusitis-inflammation-remains-difficult-to-control-despite-targeted-therapies 2026-07-02T16:10:36+00:00 hourly 0.9 https://trial.medpath.com/news/ema-launches-comprehensive-initiative-to-address-gender-gap-in-medicines-development-for-women-s-health 2026-07-02T16:10:29+00:00 hourly 0.9 https://trial.medpath.com/news/chicago-area-health-systems-race-to-expand-cancer-care-infrastructure-amid-rising-demand 2026-07-02T16:09:43+00:00 hourly 0.9 https://trial.medpath.com/news/kenya-launches-five-year-local-manufacturing-strategy-to-reduce-pharmaceutical-import-dependence 2026-07-02T16:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/nih-unveils-world-s-largest-genomics-and-health-database-linking-535000-whole-genomes-to-medical-records 2026-07-02T14:11:20+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-launches-ai-focused-postdoctoral-fellowships-in-digital-pathology-and-chemical-synthesis-prediction 2026-07-02T14:10:50+00:00 hourly 0.9 https://trial.medpath.com/news/besins-healthcare-acquires-unid-manufacturing-to-bolster-long-acting-drug-delivery-capabilities 2026-07-02T14:10:46+00:00 hourly 0.9 https://trial.medpath.com/news/advicenne-withdraws-adv7103-new-drug-application-in-the-usa-for-distal-renal-tubular-acidosis 2026-07-02T14:10:45+00:00 hourly 0.9 https://trial.medpath.com/news/glenmark-advances-phase-3-trial-of-trastuzumab-rezetecan-in-platinum-resistant-ovarian-cancer-following-dcgi-approval 2026-07-02T14:10:43+00:00 hourly 0.9 https://trial.medpath.com/news/researchers-call-for-urgent-integration-of-female-genital-schistosomiasis-screening-into-hiv-and-cervical-cancer-programmes 2026-07-02T14:10:42+00:00 hourly 0.9 https://trial.medpath.com/news/fda-infant-formula-adverse-event-reporting-gap-exposed-as-nec-lawsuits-mount-against-abbott-and-mead-johnson 2026-07-02T14:10:24+00:00 hourly 0.9 https://trial.medpath.com/news/japan-s-non-partisan-diet-members-briefed-on-hearing-loss-policy-challenges-and-regional-cancer-care-disparities 2026-07-02T14:10:01+00:00 hourly 0.9 https://trial.medpath.com/news/celea-therapeutics-secures-180-million-to-launch-first-head-to-head-phase-3-trial-of-deupirfenidone-in-ipf 2026-07-02T14:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/medically-tailored-meals-outperform-food-subsidies-in-lowering-hba1c-for-type-2-diabetes 2026-07-02T13:17:00+00:00 hourly 0.9 https://trial.medpath.com/news/inocras-and-aimedbio-partner-to-integrate-whole-genome-intelligence-into-adc-clinical-trials 2026-07-02T13:09:16+00:00 hourly 0.9 https://trial.medpath.com/news/ipsen-acquires-memo-therapeutics-in-deal-worth-up-to-eur700-million-validating-antibody-discovery-platform 2026-07-02T13:09:14+00:00 hourly 0.9 https://trial.medpath.com/news/kku-to-host-12th-allied-health-sciences-international-symposium-2027-advancing-ai-and-precision-medicine-in-health-education 2026-07-02T13:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/fda-talc-asbestos-testing-rule-withdrawal-exposes-deep-rift-between-maha-agenda-and-white-house-corporate-interests 2026-07-02T12:31:00+00:00 hourly 0.9 https://trial.medpath.com/news/easterseals-nh-breaks-ground-on-phase-ii-of-military-veterans-campus-in-franklin 2026-07-02T12:08:52+00:00 hourly 0.9 https://trial.medpath.com/news/daewoong-s-envlo-becomes-first-korean-sglt-2-inhibitor-to-enter-mena-market-in-w145-2-billion-deal 2026-07-02T09:05:34+00:00 hourly 0.9 https://trial.medpath.com/news/michigan-cyclosporiasis-outbreak-surges-past-225-cases-as-health-officials-race-to-identify-source 2026-07-02T08:06:54+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-markers-for-adhd-influence-toddler-activity-levels-landmark-study-of-80000-infants-reveals 2026-07-02T08:06:51+00:00 hourly 0.9 https://trial.medpath.com/news/peptide-ligand-discovery-for-gpcrs-a-comprehensive-primer-on-methods-tools-and-therapeutic-opportunities 2026-07-02T08:06:49+00:00 hourly 0.9 https://trial.medpath.com/news/asbmb-announces-new-committee-members-and-leadership-transitions-for-2025-2026-term 2026-07-02T06:07:16+00:00 hourly 0.9 https://trial.medpath.com/news/nuvation-bio-s-david-hung-on-building-a-pipeline-of-best-in-class-oncology-drugs 2026-07-02T06:07:16+00:00 hourly 0.9 https://trial.medpath.com/news/global-trust-in-science-remains-high-despite-political-polarization-landmark-68-country-survey-reveals 2026-07-02T06:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/federal-judge-blocks-colorado-s-first-in-nation-price-cap-on-amgen-s-arthritis-drug-enbrel 2026-07-02T06:06:25+00:00 hourly 0.9 https://trial.medpath.com/news/helix-launches-genosphere-mcp-connector-in-claude-to-accelerate-clinico-genomic-research 2026-07-02T05:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/first-synthetic-cell-built-from-scratch-achieves-growth-dna-replication-and-division 2026-07-02T05:07:32+00:00 hourly 0.9 https://trial.medpath.com/news/reversing-macrophage-metabolism-may-improve-cancer-immunotherapy-outcomes 2026-07-02T04:07:04+00:00 hourly 0.9 https://trial.medpath.com/news/florida-becomes-first-state-to-mandate-ekg-screening-for-high-school-athletes-sparking-debate-over-benefits-and-harms 2026-07-02T04:06:52+00:00 hourly 0.9 https://trial.medpath.com/news/junshi-biosciences-licenses-anti-il-17a-antibody-roconkibart-to-fosun-wanbang-in-greater-china-deal-worth-up-to-rmb-215-million-upfront 2026-07-02T02:15:02+00:00 hourly 0.9 https://trial.medpath.com/news/long-acting-drugs-market-projected-to-reach-13-3-billion-by-2033-driven-by-chronic-disease-burden-and-delivery-technology-innovation 2026-07-02T02:12:46+00:00 hourly 0.9 https://trial.medpath.com/news/the-contested-disease-how-obesity-classification-shapes-medicine-markets-and-patient-identity 2026-07-02T02:12:19+00:00 hourly 0.9 https://trial.medpath.com/news/seoul-st-mary-s-hospital-reaches-200-case-milestone-in-alzheimer-s-antibody-therapy 2026-07-02T02:12:09+00:00 hourly 0.9 https://trial.medpath.com/news/leukaemia-uk-opens-final-project-grant-round-before-2027-pause-offering-up-to-ps250000-for-translational-blood-cancer-research 2026-07-02T01:07:57+00:00 hourly 0.9 https://trial.medpath.com/news/nona-biosciences-and-lonza-forge-strategic-collaboration-to-develop-single-domain-antibody-bbb-crossing-technology-for-cns-diseases 2026-07-02T01:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/treatments-have-leveled-cholesterol-and-blood-pressure-in-adults-over-40-with-obesity-landmark-lancet-study-finds 2026-07-02T01:06:50+00:00 hourly 0.9 https://trial.medpath.com/news/new-ats-cap-guidance-sparks-first-idsa-split-in-two-decades-over-empiric-antibiotics-in-viral-pneumonia 2026-07-01T22:09:22+00:00 hourly 0.9 https://trial.medpath.com/news/blood-test-may-predict-which-colorectal-cancer-patients-benefit-from-adjuvant-chemotherapy-after-liver-metastasis-surgery 2026-07-01T22:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/fondazione-telethon-to-lead-eur30-million-erdera-call-for-rare-disease-clinical-trials 2026-07-01T22:08:40+00:00 hourly 0.9 https://trial.medpath.com/news/heat-wave-warning-common-medications-that-increase-risk-of-heat-related-illness 2026-07-01T21:09:29+00:00 hourly 0.9 https://trial.medpath.com/news/csf-turnover-dysfunction-identified-as-hidden-early-biomarker-in-irbd-offering-new-window-for-parkinson-s-intervention 2026-07-01T21:08:33+00:00 hourly 0.9 https://trial.medpath.com/news/aahrpp-awards-full-accreditation-to-merck-medstar-health-and-three-other-research-entities 2026-07-01T21:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/ai-analysis-reveals-over-250000-cancer-research-papers-show-signs-of-paper-mill-fabrication 2026-07-01T20:13:10+00:00 hourly 0.9 https://trial.medpath.com/news/trop2-identified-as-achilles-heel-of-aggressive-metastatic-colorectal-cancer-paving-way-for-adc-combination-therapy 2026-07-01T20:12:17+00:00 hourly 0.9 https://trial.medpath.com/news/melatonin-shows-comparable-efficacy-to-opioids-and-nsaids-for-chronic-musculoskeletal-pain-large-meta-analysis-finds 2026-07-01T20:11:13+00:00 hourly 0.9 https://trial.medpath.com/news/aob-pharma-partners-with-biorasi-to-accelerate-phase-2b-trial-of-b244-in-moderate-to-severe-acne 2026-07-01T20:11:07+00:00 hourly 0.9 https://trial.medpath.com/news/immunotherapy-alone-achieves-complete-response-in-mismatch-repair-deficient-gastroesophageal-junction-cancer-sparing-patient-from-chemotherapy-and-surgery 2026-07-01T20:11:06+00:00 hourly 0.9 https://trial.medpath.com/news/eighth-circuit-denies-novartis-injunction-upholds-missouri-law-mandating-unlimited-340b-contract-pharmacy-access 2026-07-01T20:10:57+00:00 hourly 0.9 https://trial.medpath.com/news/moderna-attracts-heavy-call-option-activity-as-market-bets-on-biotech-upside 2026-07-01T19:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/atrx-mutations-reshape-chromatin-architecture-to-drive-glioma-progression-exposing-hoxa-as-a-therapeutic-target 2026-07-01T19:06:43+00:00 hourly 0.9 https://trial.medpath.com/news/biallelic-ehmt2-variants-identified-in-second-ever-case-of-autosomal-recessive-kleefstra-like-neurodevelopmental-syndrome 2026-07-01T18:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/92bio-doses-first-patient-in-phase-1-trial-of-ntb-928-a-next-generation-bispecific-t-cell-engager-for-platinum-resistant-ovarian-cancer 2026-07-01T18:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/duke-heart-specialists-patel-and-shah-named-to-top-aha-volunteer-leadership-posts-for-2026-27 2026-07-01T18:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/machine-learning-and-chemical-features-unlock-mycomembrane-permeation-in-mycobacterium-tuberculosis 2026-07-01T18:06:52+00:00 hourly 0.9 https://trial.medpath.com/news/unitedhealthcare-announces-august-2026-policy-updates-new-genetic-testing-prior-authorization-dme-process-changes-and-state-level-medicaid-reforms 2026-07-01T18:06:44+00:00 hourly 0.9 https://trial.medpath.com/news/uc-san-diego-researchers-uncover-structural-basis-of-congenital-myasthenic-syndromes-paving-way-for-precision-therapies 2026-07-01T17:09:25+00:00 hourly 0.9 https://trial.medpath.com/news/oregon-psilocybin-program-raises-safety-concerns-as-use-expands-beyond-medical-indications-johns-hopkins-study-finds 2026-07-01T17:09:24+00:00 hourly 0.9 https://trial.medpath.com/news/lef1-identified-as-master-regulator-of-stem-t-cells-opening-new-therapeutic-avenues-across-chronic-diseases 2026-07-01T17:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/phase-3-solaris-trial-subcutaneous-olanzapine-lai-demonstrates-efficacy-without-pdss-in-schizophrenia 2026-07-01T17:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/oral-shigella-vaccine-candidate-wrss2-demonstrates-89-efficacy-in-phase-2-controlled-human-infection-trial 2026-07-01T17:08:09+00:00 hourly 0.9 https://trial.medpath.com/news/fda-device-authorizations-rise-in-h1-2026-but-approval-timelines-lengthen-significantly 2026-07-01T17:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/lupin-secures-ema-approval-for-pediatric-expansion-of-rare-disease-drug-namuscla-in-non-dystrophic-myotonia 2026-07-01T16:07:54+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-mannkind-s-furoscix-readyflow-the-first-autoinjector-for-iv-equivalent-diuretic-therapy-in-heart-failure-and-ckd 2026-07-01T16:07:13+00:00 hourly 0.9 https://trial.medpath.com/news/polaritybio-submits-bla-for-skinte-a-first-in-class-autologous-therapy-for-diabetic-foot-ulcers 2026-07-01T16:07:10+00:00 hourly 0.9 https://trial.medpath.com/news/blood-based-circular-rna-biomarkers-outperform-ptau217-in-early-alzheimer-s-detection-landmark-nature-medicine-study-shows 2026-07-01T15:07:13+00:00 hourly 0.9 https://trial.medpath.com/news/researchers-identify-hif2-as-key-driver-of-coronary-damage-in-kawasaki-disease-opening-new-therapeutic-avenues 2026-07-01T14:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/uta-launches-disease-anchored-ph-d-program-to-accelerate-rare-disease-research-and-treatment 2026-07-01T14:08:36+00:00 hourly 0.9 https://trial.medpath.com/news/johnson-johnson-ranks-ninth-in-gartner-s-2026-global-supply-chain-top-25-showcasing-ai-driven-resilience 2026-07-01T14:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/rigel-pharmaceuticals-appoints-board-member-alison-l-hannah-m-d-as-chief-medical-officer-to-drive-oncology-pipeline 2026-07-01T14:08:08+00:00 hourly 0.9 https://trial.medpath.com/news/medical-commercial-alignment-in-rare-disease-launches-fails-long-before-launch-day-experts-warn 2026-07-01T14:06:52+00:00 hourly 0.9 https://trial.medpath.com/news/mankind-pharma-partners-with-denovo-sciences-to-launch-ai-driven-drug-discovery-program 2026-07-01T14:06:51+00:00 hourly 0.9 https://trial.medpath.com/news/mepolizumab-demonstrates-disease-stability-benefits-across-copd-severity-spectrum-at-ats-2026 2026-07-01T14:06:48+00:00 hourly 0.9 https://trial.medpath.com/news/from-ions-to-immunotherapy-how-a-st-jude-scientist-is-designing-a-car-t-cell-trial-for-pediatric-brain-tumors 2026-07-01T13:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/ai-and-data-driven-approaches-poised-to-bridge-the-gap-between-cardiovascular-modeling-and-clinical-practice 2026-07-01T12:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/fda-issues-complete-response-letter-to-galderma-for-relabotulinumtoxina-over-manufacturing-observations 2026-07-01T12:07:04+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-crack-mix-and-match-code-behind-bacterial-anti-cancer-drug-assembly-opening-door-to-engineered-hdac-inhibitors 2026-07-01T12:07:00+00:00 hourly 0.9 https://trial.medpath.com/news/virtual-sustained-counseling-plus-nrt-nearly-doubles-smoking-quit-rates-in-cancer-patients-ecog-acrin-trial 2026-07-01T11:32:00+00:00 hourly 0.9 https://trial.medpath.com/news/valerio-therapeutics-to-acquire-etherna-immunotherapies-in-eur30m-deal-creating-fully-integrated-rna-medicines-company 2026-07-01T11:08:02+00:00 hourly 0.9 https://trial.medpath.com/news/former-nfl-running-back-chris-johnson-reveals-als-diagnosis-deion-sanders-declares-himself-cancer-free 2026-07-01T11:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/silk-based-bone-marrow-factories-move-lab-grown-platelets-closer-to-clinical-use 2026-07-01T10:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/skylinedx-s-merlin-cp-gep-earns-fda-breakthrough-device-designation-for-early-stage-melanoma-risk-assessment 2026-07-01T09:07:00+00:00 hourly 0.9 https://trial.medpath.com/news/telum-therapeutics-secures-eur18-million-series-a-to-advance-novel-antimicrobial-against-acinetobacter-baumannii 2026-07-01T08:07:08+00:00 hourly 0.9 https://trial.medpath.com/news/oxford-harrington-rare-disease-centre-appoints-first-little-princess-trust-professor-of-paediatric-oncology-to-accelerate-rare-childhood-cancer-drug-discovery 2026-07-01T08:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/ada-leads-coalition-opposing-proposed-rule-threatening-federal-diabetes-research-funding-as-143000-comments-filed 2026-07-01T08:06:23+00:00 hourly 0.9 https://trial.medpath.com/news/advanced-ai-for-missing-modality-learning-and-uncertainty-aware-medical-image-analysis-bridging-the-gap-between-idealized-ai-and-clinical-reality 2026-07-01T06:27:00+00:00 hourly 0.9 https://trial.medpath.com/news/vaderis-launches-global-phase-3-heroic-trial-of-engasertib-for-hereditary-hemorrhagic-telangiectasia 2026-07-01T06:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/poland-expands-hcv-treatment-to-children-as-real-world-data-confirm-high-daa-efficacy-in-pediatric-patients 2026-07-01T06:08:08+00:00 hourly 0.9 https://trial.medpath.com/news/telangana-bets-big-on-drug-discovery-hyderabad-poised-to-become-global-hub-for-next-generation-therapies 2026-07-01T06:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/intensive-diabetes-management-program-eliminates-amputations-in-south-los-angeles-safety-net-hospital 2026-07-01T04:07:28+00:00 hourly 0.9 https://trial.medpath.com/news/case-reports-reveal-individualized-risk-patterns-in-triple-negative-breast-cancer-treatment 2026-07-01T04:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/west-nile-virus-season-intensifies-california-reports-first-human-case-as-surveillance-signals-surge 2026-07-01T03:09:00+00:00 hourly 0.9 https://trial.medpath.com/news/asco-warns-of-critical-ifosfamide-shortage-threatening-cancer-treatment 2026-07-01T01:06:26+00:00 hourly 0.9 https://trial.medpath.com/news/abionyx-secures-up-to-eur33m-and-launches-pivotal-phase-2b-trial-of-cer-001-in-sepsis 2026-07-01T01:06:11+00:00 hourly 0.9 https://trial.medpath.com/news/brazil-s-patent-office-finalizes-new-guidelines-for-medical-use-inventions-accepts-post-filing-data-but-maintains-restrictions-on-dosage-regimens 2026-07-01T00:09:06+00:00 hourly 0.9 https://trial.medpath.com/news/decoding-the-ptm-code-of-cgas-sting-in-gastric-cancer-from-innate-dna-sensing-to-precision-combination-therapy 2026-07-01T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/mexico-city-unveils-us-125-million-biotech-investment-to-build-domestic-biopharmaceutical-manufacturing-capacity 2026-06-30T23:08:17+00:00 hourly 0.9 https://trial.medpath.com/news/monoclonal-antibody-alt-100-shows-early-promise-for-ards-in-proof-of-concept-trial 2026-06-30T22:13:26+00:00 hourly 0.9 https://trial.medpath.com/news/virginia-s-leading-research-universities-unite-to-advance-biomedical-innovation 2026-06-30T22:13:08+00:00 hourly 0.9 https://trial.medpath.com/news/roche-reports-clinical-trial-success-for-lung-cancer-drug 2026-06-30T22:12:38+00:00 hourly 0.9 https://trial.medpath.com/news/clinical-trial-supply-forecasting-why-data-currency-not-algorithms-drives-waste-reduction 2026-06-30T22:12:38+00:00 hourly 0.9 https://trial.medpath.com/news/phase-iii-trial-launches-to-evaluate-atezolizumab-as-first-postoperative-therapy-for-stage-i-nsclc 2026-06-30T22:12:18+00:00 hourly 0.9 https://trial.medpath.com/news/candida-auris-drug-resistant-fungus-spreads-in-u-s-healthcare-facilities-cdc-reports 2026-06-30T21:33:00+00:00 hourly 0.9 https://trial.medpath.com/news/kura-oncology-s-ziftomenib-earns-fda-approval-paving-path-for-expanded-aml-treatment-and-fti-comeback 2026-06-30T21:09:12+00:00 hourly 0.9 https://trial.medpath.com/news/stravitz-sanyal-liver-institute-opens-30-million-clinical-research-imaging-center-to-accelerate-liver-and-metabolic-disease-drug-development 2026-06-30T21:09:07+00:00 hourly 0.9 https://trial.medpath.com/news/ohio-state-launches-buckeye-biolaunch-an-ai-enabled-center-to-accelerate-therapeutic-discovery-and-commercialization 2026-06-30T21:08:55+00:00 hourly 0.9 https://trial.medpath.com/news/columbia-scientists-solve-47-year-mystery-of-malaria-invasion-design-first-invasion-blocking-mini-protein 2026-06-30T21:08:51+00:00 hourly 0.9 https://trial.medpath.com/news/pep-club-launches-full-stack-telehealth-platform-integrating-prescription-therapy-peptide-protocols-and-at-home-biomarker-testing 2026-06-30T21:08:50+00:00 hourly 0.9 https://trial.medpath.com/news/richard-dalby-retires-after-34-years-shaping-pulmonary-and-nasal-drug-delivery-science-at-university-of-maryland 2026-06-30T21:08:49+00:00 hourly 0.9 https://trial.medpath.com/news/hnklear-saliva-based-diagnostic-platform-advances-toward-clinical-use-in-head-and-neck-cancer 2026-06-30T21:08:45+00:00 hourly 0.9 https://trial.medpath.com/news/precision-nutrition-in-diabetic-foot-ulcers-ai-enabled-personalized-metabolic-management-remains-a-future-vision-not-current-reality 2026-06-30T21:08:43+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-bispecific-antibody-shuttles-unlock-dual-receptor-pathway-across-the-blood-brain-barrier 2026-06-30T20:10:13+00:00 hourly 0.9 https://trial.medpath.com/news/egypt-launches-first-national-rare-diseases-forum-unveils-comprehensive-patient-support-strategy 2026-06-30T20:09:51+00:00 hourly 0.9 https://trial.medpath.com/news/med-el-acquires-two-gene-therapy-programs-from-rescue-hearing-targeting-myo7a-and-strc-mutations-for-hearing-and-balance-disorders 2026-06-30T20:09:37+00:00 hourly 0.9 https://trial.medpath.com/news/inductive-bio-launches-admet-prediction-connector-for-anthropic-s-claude-democratizing-ai-powered-drug-discovery 2026-06-30T19:09:55+00:00 hourly 0.9 https://trial.medpath.com/news/pharmacists-warned-diverted-hiv-medicines-sold-on-online-p2p-platforms-pose-serious-patient-risk 2026-06-30T19:09:51+00:00 hourly 0.9 https://trial.medpath.com/news/dual-target-focused-ultrasound-delivers-immediate-relief-in-advanced-parkinson-s-as-bilateral-ptt-data-back-fda-approval 2026-06-30T19:09:42+00:00 hourly 0.9 https://trial.medpath.com/news/anti-lipid-antibodies-show-promise-for-earlier-lyme-disease-detection 2026-06-30T19:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/gadi-lachman-trinetx-founder-joins-srotas-health-board-to-advance-ai-driven-clinical-trial-recruitment 2026-06-30T19:08:41+00:00 hourly 0.9 https://trial.medpath.com/news/allucent-launches-ignitetm-site-network-to-accelerate-clinical-trial-execution-for-small-and-mid-sized-biopharma 2026-06-30T19:07:27+00:00 hourly 0.9 https://trial.medpath.com/news/infant-feeding-mode-shapes-gut-microbiome-composition-and-function-in-egyptian-neonates 2026-06-30T18:07:05+00:00 hourly 0.9 https://trial.medpath.com/news/cdc-alerts-clinicians-to-surge-in-u-s-rabies-exposures-as-fatal-pediatric-case-highlights-pep-gaps 2026-06-30T18:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/altasciences-completes-pivotal-toxicology-study-for-steel-therapeutics-fizurextm-clearing-path-to-ind-filing-for-anal-fissure-treatment 2026-06-30T18:06:54+00:00 hourly 0.9 https://trial.medpath.com/news/uc-san-diego-launches-12-3-million-brain-frame-program-to-improve-brain-health-in-people-with-hiv-and-methamphetamine-use-disorder 2026-06-30T18:06:38+00:00 hourly 0.9 https://trial.medpath.com/news/fralin-biomedical-research-institute-awards-tenure-to-five-faculty-advancing-neuroscience-pulmonary-disease-and-health-behavior-research 2026-06-30T18:06:22+00:00 hourly 0.9 https://trial.medpath.com/news/washington-university-launches-1-47m-trial-to-test-whether-insomnia-drug-suvorexant-can-slow-alzheimer-s-pathology 2026-06-30T18:06:18+00:00 hourly 0.9 https://trial.medpath.com/news/vector-science-therapeutics-files-provisional-patent-for-magnetic-patch-based-transdermal-peptide-delivery-platform 2026-06-30T18:06:04+00:00 hourly 0.9 https://trial.medpath.com/news/dietary-protein-intake-shows-promise-for-reversing-hair-loss-clinical-evidence-and-expert-insights 2026-06-30T17:32:00+00:00 hourly 0.9 https://trial.medpath.com/news/alr-technologies-to-acquire-cgm-medical-in-45-million-deal-securing-continuous-glucose-monitor-manufacturing 2026-06-30T17:09:18+00:00 hourly 0.9 https://trial.medpath.com/news/nanosensor-distinguishes-autism-from-intellectual-disability-using-nitric-oxide-biomarker-in-patient-stem-cells 2026-06-30T17:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/early-qc-planning-is-the-make-or-break-factor-in-cell-and-gene-therapy-development 2026-06-30T16:10:12+00:00 hourly 0.9 https://trial.medpath.com/news/dkfz-researchers-secure-erc-funding-to-advance-a-lock-and-kill-gene-therapy-for-glioblastoma 2026-06-30T16:09:55+00:00 hourly 0.9 https://trial.medpath.com/news/uk-pharma-transparency-database-hits-record-ps929-6-million-in-2025-driven-by-r-d-growth-and-new-disclosure-guidance 2026-06-30T16:09:54+00:00 hourly 0.9 https://trial.medpath.com/news/headlands-research-acquires-clinical-trials-research-bolstering-cardiometabolic-trial-capabilities-in-california 2026-06-30T16:09:48+00:00 hourly 0.9 https://trial.medpath.com/news/lancet-review-mrna-vaccines-94-effective-against-covid-19-death-serious-adverse-events-remain-rare-across-billions-of-doses 2026-06-30T16:09:29+00:00 hourly 0.9 https://trial.medpath.com/news/creative-biolabs-launches-integrated-glycorna-analysis-platform-for-rna-glycobiology-and-biomarker-discovery 2026-06-30T16:09:26+00:00 hourly 0.9 https://trial.medpath.com/news/nih-s-all-of-us-program-releases-major-dataset-expansion-linking-535000-genomes-with-ehr-data-to-advance-precision-medicine 2026-06-30T16:08:58+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-breakthrough-therapy-designation-to-kowa-s-pemafibrate-k-808-for-primary-biliary-cholangitis 2026-06-30T16:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/ai-enabled-imaging-modalities-market-to-surge-from-3-62-billion-to-15-16-billion-by-2035-driven-by-deep-learning-and-hospital-demand 2026-06-30T15:34:00+00:00 hourly 0.9 https://trial.medpath.com/news/adragos-and-towa-forge-strategic-partnership-to-supply-1-5-billion-off-patent-tablets-annually-from-japan-facility 2026-06-30T15:08:09+00:00 hourly 0.9 https://trial.medpath.com/news/tga-warns-multiple-sexual-enhancement-supplements-contain-hidden-prescription-drugs 2026-06-30T15:07:24+00:00 hourly 0.9 https://trial.medpath.com/news/anixa-biosciences-wins-australian-patent-acceptance-for-breast-cancer-vaccine-expanding-global-ip-estate 2026-06-30T15:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/aspen-neuroscience-completes-dosing-in-cohorts-3-and-4-of-phase-1-2a-aspiro-trial-for-parkinson-s-disease-cell-therapy 2026-06-30T15:07:21+00:00 hourly 0.9 https://trial.medpath.com/news/flare-therapeutics-secures-85m-series-c-appoints-anna-protopapas-as-ceo-to-advance-first-in-class-aron-degrader-for-prostate-cancer 2026-06-30T15:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/erc-awards-proof-of-concept-grants-to-182-researchers-including-three-at-tu-darmstadt 2026-06-30T14:08:33+00:00 hourly 0.9 https://trial.medpath.com/news/aptevo-files-patent-for-nectin-4-x-pd-l1-dual-targeting-backbone-to-expand-solid-tumor-strategy 2026-06-30T14:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/canadian-patients-with-metastatic-melanoma-face-life-threatening-delays-as-til-therapy-awaits-provincial-funding 2026-06-30T13:09:27+00:00 hourly 0.9 https://trial.medpath.com/news/exonate-appoints-olav-hellebo-as-ceo-advances-topical-vegf-eye-drop-toward-phase-iib-trial 2026-06-30T13:09:24+00:00 hourly 0.9 https://trial.medpath.com/news/global-experts-release-second-universal-definition-of-heart-failure-shifting-focus-to-early-detection-and-disease-trajectory 2026-06-30T13:08:28+00:00 hourly 0.9 https://trial.medpath.com/news/fda-advisory-panel-unanimously-backs-moderna-s-mrna-flu-vaccine-setting-stage-for-first-mrna-seasonal-flu-shot 2026-06-30T13:08:13+00:00 hourly 0.9 https://trial.medpath.com/news/real-world-prosper-data-show-mogamulizumab-provides-rapid-sustained-symptom-relief-in-mycosis-fungoides-and-sezary-syndrome 2026-06-30T12:48:00+00:00 hourly 0.9 https://trial.medpath.com/news/pennsylvania-s-drug-delivery-resulting-in-death-law-a-mother-s-fight-exposes-the-complex-reality-of-prosecuting-overdoses-as-homicides 2026-06-30T12:33:00+00:00 hourly 0.9 https://trial.medpath.com/news/multi-antigen-t-cell-therapy-shows-safety-and-durable-responses-in-pediatric-brain-tumors-phase-1-remind-trial 2026-06-30T12:09:04+00:00 hourly 0.9 https://trial.medpath.com/news/tumour-glycolysis-drives-vascular-dysfunction-and-immunotherapy-resistance-preclinical-study-shows 2026-06-30T12:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/post-meal-fiber-shots-and-glucose-gummies-navigating-the-metabolic-wellness-market-without-medical-claims 2026-06-30T12:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/pfas-free-alternatives-exist-for-87-of-human-medicines-landmark-university-of-freiburg-report-finds 2026-06-30T11:06:34+00:00 hourly 0.9 https://trial.medpath.com/news/sirpad-sirolimus-coated-balloons-cut-amputation-and-revascularization-in-infrainguinal-pad 2026-06-30T11:06:29+00:00 hourly 0.9 https://trial.medpath.com/news/metis-techbio-licenses-ai-designed-trispecific-t-cell-engager-mts-128-to-boulevard-bio-in-deal-worth-up-to-1-6-billion 2026-06-30T11:06:26+00:00 hourly 0.9 https://trial.medpath.com/news/kff-poll-lack-of-trusted-provider-and-social-media-use-linked-to-vaccine-myth-belief 2026-06-30T10:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/me-cfs-research-foundation-invests-eur2-4-million-in-seven-new-research-projects-across-germany 2026-06-30T09:10:25+00:00 hourly 0.9 https://trial.medpath.com/news/sanofi-s-nexviazyme-meets-all-endpoints-in-phase-iii-baby-comet-trial-for-infantile-onset-pompe-disease 2026-06-30T09:09:51+00:00 hourly 0.9 https://trial.medpath.com/news/embl-spin-off-epitome-therapeutics-launches-with-eur4m-to-pioneer-precision-epigenome-editing-for-gene-activation 2026-06-30T09:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/creatine-as-an-add-on-therapy-for-depression-systematic-review-reveals-mixed-evidence-calls-for-larger-trials 2026-06-30T09:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/closing-the-scale-up-gap-manufacturing-challenges-and-innovations-in-cell-and-gene-therapy 2026-06-30T08:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/stem-cell-based-biologics-emerge-as-promising-strategy-for-vascular-repair-amid-persistent-translational-hurdles 2026-06-30T07:11:58+00:00 hourly 0.9 https://trial.medpath.com/news/space-travel-does-not-significantly-impair-cardiac-sarcomere-function-but-triggers-immune-related-proteomic-changes 2026-06-30T07:11:55+00:00 hourly 0.9 https://trial.medpath.com/news/ab-science-s-ab8939-plus-venetoclax-achieves-67-orr-in-phase-1-trial-for-high-risk-relapsed-refractory-aml 2026-06-30T07:10:23+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-priority-review-to-roche-s-enspryng-as-first-at-home-subcutaneous-therapy-for-thyroid-eye-disease 2026-06-30T07:09:57+00:00 hourly 0.9 https://trial.medpath.com/news/adjane-s-intranasal-nomv-vaccine-platform-shows-first-human-proof-of-concept-for-mucosal-immunity 2026-06-30T06:20:00+00:00 hourly 0.9 https://trial.medpath.com/news/senator-hassan-opens-investigation-into-merck-s-keytruda-patent-strategy-amid-pricing-concerns 2026-06-30T06:08:41+00:00 hourly 0.9 https://trial.medpath.com/news/nectin-4-targeted-pet-tracer-68ga-ga-fz-nr-1-outperforms-fdg-in-recurrent-or-metastatic-triple-negative-breast-cancer 2026-06-30T02:08:11+00:00 hourly 0.9 https://trial.medpath.com/news/sellas-nears-pivotal-phase-3-readout-for-galinpepimut-s-in-aml-as-regal-trial-approaches-final-analysis 2026-06-30T02:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/human-3d-organoid-models-advance-mechanistic-understanding-of-motor-neuron-diseases 2026-06-30T00:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/uc-davis-comprehensive-cancer-center-showcases-smart-nanotechnology-precision-imaging-and-high-risk-lymphoma-trial-in-summer-2026-synthesis-magazine 2026-06-30T00:07:05+00:00 hourly 0.9 https://trial.medpath.com/news/cu-anschutz-team-awarded-200000-aspire-grant-to-target-npepps-enzyme-and-overcome-dual-resistance-to-chemotherapy-and-immunotherapy 2026-06-29T23:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/study-links-sedentary-lifestyle-to-early-mitochondrial-dysfunction-in-healthy-adults 2026-06-29T23:08:50+00:00 hourly 0.9 https://trial.medpath.com/news/powassan-virus-cases-reach-record-high-of-76-in-2025-as-tick-borne-threat-expands-across-us 2026-06-29T23:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/virginia-approves-funding-for-vcu-to-acquire-altria-center-and-build-new-school-of-dentistry-facility 2026-06-29T22:09:18+00:00 hourly 0.9 https://trial.medpath.com/news/second-primary-malignancies-emerge-as-clinically-relevant-complication-of-t-cell-engaging-bispecific-antibody-therapy 2026-06-29T22:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/tumour-genetic-variants-linked-to-immunotherapy-toxicity-risk-in-urothelial-cancer 2026-06-29T22:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/eu-biotech-act-proposes-sweeping-clinical-trial-reforms-to-reverse-europe-s-declining-global-competitiveness 2026-06-29T22:08:51+00:00 hourly 0.9 https://trial.medpath.com/news/google-cloud-to-offer-sandboxaq-s-large-quantitative-ai-models-for-drug-discovery-via-marketplace 2026-06-29T21:09:01+00:00 hourly 0.9 https://trial.medpath.com/news/pharmacist-led-medication-optimization-tied-to-19-4-lower-medical-costs-in-medicare-aco-population 2026-06-29T21:08:43+00:00 hourly 0.9 https://trial.medpath.com/news/fda-selects-eli-lilly-regeneron-among-first-seven-companies-for-precheck-manufacturing-pilot-program 2026-06-29T21:07:45+00:00 hourly 0.9 https://trial.medpath.com/news/connie-cepko-retires-after-pioneering-gene-agnostic-therapies-for-inherited-retinal-disease 2026-06-29T20:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/former-nfl-star-chris-johnson-reveals-als-diagnosis-joins-experimental-clinical-trial 2026-06-29T19:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/diabetes-linked-to-worse-long-covid-recovery-higher-cardiovascular-risk-after-hospitalisation 2026-06-29T19:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/moatrx-launches-axlrx-ai-pharma-intelligence-platform-for-commercial-consulting 2026-06-29T19:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/spinal-cord-stimulation-shows-32-arm-strength-gain-in-stroke-pilot-trial 2026-06-29T18:25:00+00:00 hourly 0.9 https://trial.medpath.com/news/algeria-s-national-cancer-plan-2035-a-strategic-roadmap-for-prevention-early-detection-and-equitable-oncology-care 2026-06-29T18:10:42+00:00 hourly 0.9 https://trial.medpath.com/news/anlotinib-combined-with-pd-1-inhibitor-suppresses-mss-colorectal-cancer-via-vascular-normalization-and-immune-reprogramming 2026-06-29T18:10:03+00:00 hourly 0.9 https://trial.medpath.com/news/sellas-nears-aml-trial-readout-moderna-expands-oncology-pipeline-and-abcellera-lands-jazz-partnership-as-biotech-stocks-hit-52-week-highs 2026-06-29T18:09:57+00:00 hourly 0.9 https://trial.medpath.com/news/suic-and-visionrenu-sign-strategic-mou-to-accelerate-ai-powered-biotechnology-and-precision-medicine 2026-06-29T18:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/microvilli-trapping-of-pd-1-limits-immunotherapy-efficacy-engineered-antibody-offers-new-solution 2026-06-29T17:09:34+00:00 hourly 0.9 https://trial.medpath.com/news/biomarker-based-immunoassays-market-poised-to-reach-11-55-billion-by-2030-driven-by-ai-integration-and-rising-cancer-incidence 2026-06-29T17:09:06+00:00 hourly 0.9 https://trial.medpath.com/news/scaling-organoids-for-drug-discovery-how-automation-and-ai-are-transforming-the-dmta-cycle 2026-06-29T17:08:40+00:00 hourly 0.9 https://trial.medpath.com/news/ai-driven-high-content-screening-accelerates-phenotypic-profiling-with-up-to-100-faster-image-acquisition 2026-06-29T17:08:38+00:00 hourly 0.9 https://trial.medpath.com/news/uk-invests-ps9-7m-to-strengthen-clinical-research-careers-across-the-nhs 2026-06-29T17:06:52+00:00 hourly 0.9 https://trial.medpath.com/news/nature-medicine-highlights-nordic-ai-health-infrastructure-with-karolinska-institutet-as-key-enabler 2026-06-29T17:06:28+00:00 hourly 0.9 https://trial.medpath.com/news/medetomidine-a-potent-veterinary-sedative-emerges-as-a-dangerous-adulterant-in-illicit-fentanyl-supply-coroners-warn 2026-06-29T17:06:02+00:00 hourly 0.9 https://trial.medpath.com/news/bipartisan-senate-push-revives-35-insulin-cap-for-private-insurance-and-uninsured-patients 2026-06-29T16:10:49+00:00 hourly 0.9 https://trial.medpath.com/news/cansinobio-s-quadrivalent-meningococcal-conjugate-vaccine-menhycia-r-receives-registration-approval-in-argentina 2026-06-29T16:09:37+00:00 hourly 0.9 https://trial.medpath.com/news/dupilumab-shows-significant-tissue-level-improvements-in-phase-2-trial-for-eosinophilic-gastritis 2026-06-29T16:09:32+00:00 hourly 0.9 https://trial.medpath.com/news/california-s-8-4-billion-immunology-research-bond-heads-to-voters-amid-federal-funding-crisis 2026-06-29T15:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/flow-imaging-microscopy-bridges-the-gap-in-subvisible-particle-testing-for-biologics-usp-stimuli-article-says 2026-06-29T15:08:22+00:00 hourly 0.9 https://trial.medpath.com/news/health-canada-approves-expansion-of-biodexa-s-serenta-phase-3-trial-for-familial-adenomatous-polyposis 2026-06-29T14:07:53+00:00 hourly 0.9 https://trial.medpath.com/news/ista-researchers-develop-experiment-guided-alphafold-to-capture-protein-dynamics 2026-06-29T14:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/dyadic-secures-japanese-patent-for-c1-recombinant-protein-platform-accelerates-asia-pacific-expansion 2026-06-29T14:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/the-right-way-to-tackle-developing-countries-cancer-crisis-why-weakening-ip-protections-is-not-the-answer 2026-06-29T13:08:52+00:00 hourly 0.9 https://trial.medpath.com/news/ai-driven-psoriasis-care-evolves-toward-multimodal-diagnosis-and-personalized-treatment-bibliometric-analysis-reveals 2026-06-29T13:08:51+00:00 hourly 0.9 https://trial.medpath.com/news/alebund-pharmaceuticals-debuts-on-hong-kong-stock-exchange-raising-164-million-to-advance-broad-renal-pipeline 2026-06-29T13:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/comprehensive-genomic-profiling-in-nsclc-lab-processing-improves-but-biopsy-to-order-delays-persist 2026-06-29T13:08:43+00:00 hourly 0.9 https://trial.medpath.com/news/a-retired-drug-researcher-s-journey-through-alzheimer-s-diagnosis-highlights-gaps-in-patient-access-to-early-information 2026-06-29T13:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/body-fluid-analysis-market-projected-to-reach-3-65-billion-by-2031-driven-by-biomarker-based-diagnostics-and-laboratory-automation 2026-06-29T12:12:16+00:00 hourly 0.9 https://trial.medpath.com/news/talawar-therapeutics-to-go-public-via-spac-merger-secures-225m-pipe-to-advance-bispecific-antibody-for-atopic-dermatitis 2026-06-29T12:12:14+00:00 hourly 0.9 https://trial.medpath.com/news/viatris-reports-positive-phase-3-results-for-vr-205-in-japanese-adults-with-iga-nephropathy-targets-2026-nda-submission 2026-06-29T12:11:07+00:00 hourly 0.9 https://trial.medpath.com/news/chmp-recommends-hopledo-ipx203-for-parkinson-s-disease-with-motor-fluctuations-paving-way-for-eu-approval 2026-06-29T12:09:50+00:00 hourly 0.9 https://trial.medpath.com/news/repeated-high-voltage-pulsed-radiofrequency-reduces-postherpetic-neuralgia-incidence-in-diabetic-patients-with-thoracic-herpes-zoster 2026-06-29T12:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/crispr-gene-editing-roadmap-targets-28000-discarded-donor-organs-annually-via-machine-perfusion-window 2026-06-29T12:08:58+00:00 hourly 0.9 https://trial.medpath.com/news/gist-and-k-medi-hub-secure-national-funding-to-develop-oral-cd73-targeting-immuno-oncology-drug 2026-06-29T11:08:39+00:00 hourly 0.9 https://trial.medpath.com/news/natera-and-aveta-biomics-partner-on-global-phase-3-trial-of-oral-immunotherapy-apg-157-in-head-and-neck-cancer 2026-06-29T11:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/ever-supreme-s-allogeneic-car-t-car001-clears-phase-i-safety-review-advances-to-phase-iia-in-solid-tumors 2026-06-29T11:07:01+00:00 hourly 0.9 https://trial.medpath.com/news/roche-launches-axelios-1-a-next-generation-sequencing-platform-delivering-same-day-whole-genome-results 2026-06-29T11:07:00+00:00 hourly 0.9 https://trial.medpath.com/news/one-person-a-week-dies-with-undiagnosed-tb-in-england-study-finds 2026-06-29T11:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/clive-meanwell-bets-on-ai-to-replicate-metsera-style-bidding-war-success-in-population-health 2026-06-29T11:06:57+00:00 hourly 0.9 https://trial.medpath.com/news/tolerogenixx-completes-last-patient-transplant-in-phase-iib-tol-2-trial-of-mic-lx-a-first-in-class-immune-tolerance-cell-therapy-for-kidney-transplantation 2026-06-29T09:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/doset-new-adaptive-trial-design-improves-dose-optimization-for-car-t-cell-therapy-in-early-phase-cancer-studies 2026-06-29T08:10:48+00:00 hourly 0.9 https://trial.medpath.com/news/parp-inhibitors-expand-beyond-brca-mutated-cancers-emerging-evidence-across-solid-tumors-and-combination-strategies 2026-06-29T08:10:19+00:00 hourly 0.9 https://trial.medpath.com/news/revvity-signals-launches-signals-ai-agentic-framework-to-transform-r-d-data-into-actionable-scientific-insights 2026-06-29T08:09:46+00:00 hourly 0.9 https://trial.medpath.com/news/zelluna-doses-first-patient-with-world-s-first-mage-a4-targeting-tcr-nk-therapy-in-phase-1-solid-tumour-trial 2026-06-29T07:10:29+00:00 hourly 0.9 https://trial.medpath.com/news/ipsen-acquires-kartos-therapeutics-for-450m-to-develop-navtemadlin-an-mdm2-inhibitor-for-myelofibrosis 2026-06-29T06:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/professor-gina-ravenscroft-appointed-inaugural-dr-patricia-kailis-chair-in-rare-diseases-at-uwa 2026-06-29T06:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/excess-visceral-fat-linked-to-accelerated-biological-ageing-study-finds 2026-06-29T06:06:50+00:00 hourly 0.9 https://trial.medpath.com/news/lab-grown-retinas-to-advance-gene-therapy-for-inherited-blindness-win-nsw-government-grant 2026-06-29T04:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/india-expands-mandatory-qr-code-traceability-to-all-vaccines-antimicrobials-narcotics-and-anti-cancer-drugs 2026-06-29T04:07:06+00:00 hourly 0.9 https://trial.medpath.com/news/nasal-commensal-viruses-may-drive-allergic-rhinitis-ribavirin-spray-shows-early-promise-in-phase-2-trial 2026-06-29T02:08:39+00:00 hourly 0.9 https://trial.medpath.com/news/gc-wellbeing-licenses-raziel-s-next-generation-fat-dissolving-injectable-eyes-phase-3-entry 2026-06-29T01:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/new-sensor-listens-to-mini-hearts-poised-to-transform-cardiac-drug-development 2026-06-29T00:10:38+00:00 hourly 0.9 https://trial.medpath.com/news/japanese-startup-pormedtec-to-launch-japan-s-first-pig-to-human-kidney-transplant-clinical-trials-by-2028 2026-06-29T00:09:49+00:00 hourly 0.9 https://trial.medpath.com/news/magnesium-supplements-show-limited-clinical-benefit-in-healthy-populations-experts-emphasize-dietary-sources 2026-06-29T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/senator-bill-cassidy-accuses-hhs-secretary-rfk-jr-of-lying-about-vaccine-autism-commitments-warns-of-erosion-in-public-health-trust 2026-06-28T23:09:01+00:00 hourly 0.9 https://trial.medpath.com/news/5-million-americans-drop-aca-coverage-after-enhanced-subsidies-expire-raising-public-health-concerns 2026-06-28T23:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/venture-capital-surge-propels-catalonia-s-life-sciences-sector-to-record-investment-heights 2026-06-28T20:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/plasma-inflammation-profiles-linked-to-cognition-via-distinct-pathways-in-alzheimer-s-disease 2026-06-28T20:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/rising-tide-of-phone-addiction-prompts-new-treatment-approaches-as-uk-clinics-report-surge-in-digital-dependency 2026-06-28T20:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/histotripsy-gains-traction-as-noninvasive-ultrasound-based-liver-tumor-ablation-expands-across-u-s-centers 2026-06-28T19:08:45+00:00 hourly 0.9 https://trial.medpath.com/news/world-s-first-agi-smart-city-clinical-trial-opens-enrollment-for-veterans-and-mental-health-populations 2026-06-28T19:08:41+00:00 hourly 0.9 https://trial.medpath.com/news/nhs-eligibility-criteria-deny-secondary-breast-cancer-patient-access-to-promising-drug-forcing-ps200000-private-fundraising-campaign 2026-06-28T18:09:08+00:00 hourly 0.9 https://trial.medpath.com/news/iran-approves-whartocell-an-off-the-shelf-allogeneic-umbilical-cord-stem-cell-therapy-for-osteoarthritis 2026-06-28T18:07:54+00:00 hourly 0.9 https://trial.medpath.com/news/gut-fungi-linked-to-pediatric-allergic-disease-development-landmark-studies-reveal 2026-06-28T18:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/young-cancer-survivor-inspired-by-suffolk-doctors-to-pursue-medicine 2026-06-28T18:07:45+00:00 hourly 0.9 https://trial.medpath.com/news/low-intensity-ultrasound-may-shift-immune-cells-toward-healing-offering-a-non-invasive-strategy-against-post-traumatic-osteoarthritis 2026-06-28T15:12:00+00:00 hourly 0.9 https://trial.medpath.com/news/yuhan-corporation-presents-phase-1b-results-for-novel-anti-ige-allergy-drug-lesigercept-at-eaaci-2026 2026-06-28T14:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/amgen-recalls-nearly-1-million-bottles-of-corlanor-and-sensipar-over-foreign-matter-contamination 2026-06-28T14:08:29+00:00 hourly 0.9 https://trial.medpath.com/news/israeli-life-sciences-investments-plunge-40-in-2025-amid-geopolitical-headwinds-ai-driven-drug-development-emerges-as-bright-spot 2026-06-28T12:08:48+00:00 hourly 0.9 https://trial.medpath.com/news/the-broken-math-of-drug-pricing-how-a-1000-a-day-hepatitis-c-cure-exposed-the-value-gap-in-u-s-pharmaceuticals 2026-06-28T12:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/china-issues-world-s-first-ai-bci-eeg-data-standard-as-fda-and-ema-lag 2026-06-28T12:08:22+00:00 hourly 0.9 https://trial.medpath.com/news/seven-maternal-deaths-in-rajasthan-trigger-nationwide-oxytocin-safety-probe-who-seeks-report 2026-06-28T12:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/nanox-reports-q1-2026-revenue-growth-withdraws-annual-guidance-amid-slower-commercialization 2026-06-28T11:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/intraoperative-frozen-section-analysis-after-neoadjuvant-chemotherapy-leads-to-unnecessary-alnd-in-node-negative-breast-cancer-patients 2026-06-28T10:08:40+00:00 hourly 0.9 https://trial.medpath.com/news/ai-identifies-distinct-migraine-patient-patterns-beyond-headache-symptoms 2026-06-28T10:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/bernstein-resumes-thermo-fisher-coverage-sees-improving-life-science-tools-sector 2026-06-28T07:07:41+00:00 hourly 0.9 https://trial.medpath.com/news/alzheimer-s-research-advances-and-hawaii-s-legislative-action-take-center-stage-at-2026-brain-health-summit 2026-06-28T05:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/experts-call-for-strengthened-pandemic-preparedness-one-health-approach-and-combating-antimicrobial-resistance 2026-06-28T03:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/75-year-old-chinese-grandfather-becomes-beauty-influencer-to-fund-grandson-s-sma-gene-therapy 2026-06-28T02:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/ptc-therapeutics-launches-sephience-for-pku-with-125m-in-q1-sales-and-500m-convertible-note-offering 2026-06-28T00:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/enliven-therapeutics-advances-elvn-001-toward-pivotal-phase-3-trial-in-cml-amid-strong-financial-position 2026-06-27T23:08:05+00:00 hourly 0.9 https://trial.medpath.com/news/unilag-and-nafdac-call-for-scientific-validation-and-regulation-of-african-traditional-medicine 2026-06-27T23:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/redwire-opens-indiana-facility-to-advance-microgravity-based-drug-development 2026-06-27T22:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/oruka-therapeutics-rides-orka-001-psoriasis-data-momentum-as-key-everlast-a-readout-looms 2026-06-27T21:08:32+00:00 hourly 0.9 https://trial.medpath.com/news/blood-metabolism-maps-how-lifestyle-tracks-function-in-cognitive-aging 2026-06-27T21:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/how-a-tech-founder-used-ai-to-navigate-a-rare-lymphoma-diagnosis-and-avoid-unnecessary-radiotherapy 2026-06-27T20:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/neuphoria-confirms-merger-talks-with-scancell-as-uk-biotech-eyes-nasdaq-listing 2026-06-27T20:07:36+00:00 hourly 0.9 https://trial.medpath.com/news/multi-decade-analysis-reveals-shifting-patterns-of-subsequent-primary-cancer-risk-among-survivors 2026-06-27T20:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/long-island-oncology-ceo-jeff-vacirca-emerges-as-fda-commissioner-candidate-amid-agency-leadership-vacuum 2026-06-27T20:07:30+00:00 hourly 0.9 https://trial.medpath.com/news/gut-microbiome-testing-emerges-as-a-preventive-diagnostic-tool-for-mexico-s-chronic-disease-crisis 2026-06-27T19:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/sidra-medicine-launches-specialized-microbiome-service-to-advance-precision-care-for-women-and-children 2026-06-27T19:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/india-to-launch-aarogya-setu-2-0-and-national-drug-registry-in-major-digital-health-push 2026-06-27T17:09:12+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-first-targeted-therapy-for-ultra-rare-kidney-disease-ic-mpgn-pegcetacoplan-shows-rapid-clinical-benefit 2026-06-27T17:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/india-charts-path-to-precision-medicine-leadership-with-gene-therapy-genomics-and-ai-driven-healthcare 2026-06-27T17:07:57+00:00 hourly 0.9 https://trial.medpath.com/news/savara-cfo-exercises-options-as-company-approaches-pdufa-date-for-molbreevi-in-autoimmune-pulmonary-alveolar-proteinosis 2026-06-27T17:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/study-finds-nine-in-10-nairobi-pharmacies-stocking-non-compliant-imported-medicines 2026-06-27T17:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/stockholm3-blood-test-detects-90-of-aggressive-prostate-cancers-outperforming-standard-psa-screening 2026-06-27T15:11:23+00:00 hourly 0.9 https://trial.medpath.com/news/severe-sunburns-permanently-increase-skin-cancer-risk-but-prevention-and-research-offer-hope 2026-06-27T15:11:21+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-variants-in-oxidative-stress-genes-explain-why-air-pollution-hits-some-asthma-patients-harder-than-others 2026-06-27T15:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/first-in-human-trial-of-photoswitch-drug-shows-promise-for-restoring-vision-in-retinitis-pigmentosa 2026-06-27T15:08:56+00:00 hourly 0.9 https://trial.medpath.com/news/atlanta-s-ebola-preparedness-tested-as-congo-team-arrives-for-world-cup-amid-deadly-outbreak 2026-06-27T12:09:05+00:00 hourly 0.9 https://trial.medpath.com/news/thermo-fisher-scientific-launches-x2-and-s2-series-centrifuges-with-natural-refrigerant-cooling-marking-industry-first-complete-portfolio 2026-06-27T11:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/pennsylvania-confirms-two-measles-associated-deaths-first-in-35-years-as-outbreak-tops-393-cases 2026-06-27T09:10:06+00:00 hourly 0.9 https://trial.medpath.com/news/home-blood-testing-devices-market-projected-to-reach-us-51-2-billion-by-2034-as-glucose-monitoring-dominates 2026-06-27T09:09:42+00:00 hourly 0.9 https://trial.medpath.com/news/states-intensify-legislative-push-to-regulate-pharmacy-benefit-managers-amid-rising-drug-cost-concerns 2026-06-27T08:08:58+00:00 hourly 0.9 https://trial.medpath.com/news/neurocosmetics-the-emerging-science-of-skin-nervous-system-communication-in-dermatology 2026-06-27T08:08:57+00:00 hourly 0.9 https://trial.medpath.com/news/nurix-therapeutics-pipeline-review-btk-degraders-and-targeted-protein-degradation-advance-in-b-cell-malignancies 2026-06-27T08:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/boston-scientific-s-mandarin-trial-compares-therasphere-against-chemoembolization-in-chinese-liver-cancer-patients 2026-06-27T07:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/singapore-nurses-seek-s-2-4-million-for-baby-s-sma-gene-therapy-as-rare-disease-families-face-stark-realities 2026-06-27T06:09:38+00:00 hourly 0.9 https://trial.medpath.com/news/otraces-awarded-2-million-florida-grant-to-validate-proteomic-blood-test-for-reducing-unnecessary-prostate-biopsies 2026-06-27T05:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/brian-tsuji-takes-helm-at-cu-anschutz-skaggs-school-of-pharmacy-with-bold-top-five-vision 2026-06-27T03:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/carilion-clinic-and-fbri-expand-theranostics-clinical-trials-positioning-southwest-virginia-as-a-hub-for-targeted-radiopharmaceutical-cancer-therapies 2026-06-27T02:10:10+00:00 hourly 0.9 https://trial.medpath.com/news/uk-government-and-lilly-back-ps85-million-obesity-pathway-innovation-programme-to-transform-care-across-12-regions 2026-06-27T02:09:40+00:00 hourly 0.9 https://trial.medpath.com/news/jubilant-pharmova-secures-usfda-tentative-approval-for-pantoprazole-oral-suspension-eyes-2026-launch 2026-06-27T02:09:37+00:00 hourly 0.9 https://trial.medpath.com/news/appili-therapeutics-reports-fy2026-results-highlights-us-40m-niaid-award-for-antifungal-vaccine-and-likmez-commercial-momentum 2026-06-27T00:10:53+00:00 hourly 0.9 https://trial.medpath.com/news/idsa-warns-new-acip-charter-changes-threaten-vaccine-access-and-public-trust 2026-06-27T00:10:03+00:00 hourly 0.9 https://trial.medpath.com/news/keynote-966-long-term-follow-up-confirms-durable-survival-benefit-and-manageable-safety-of-pembrolizumab-chemoimmunotherapy 2026-06-27T00:09:56+00:00 hourly 0.9 https://trial.medpath.com/news/texas-a-m-researchers-develop-laser-technique-that-directly-measures-quantum-forces-driving-protein-interactions 2026-06-27T00:09:51+00:00 hourly 0.9 https://trial.medpath.com/news/uconn-school-of-pharmacy-renamed-to-school-of-pharmacy-and-pharmaceutical-sciences 2026-06-27T00:09:39+00:00 hourly 0.9 https://trial.medpath.com/news/universe-pharmaceuticals-acquires-best-praise-international-for-10-75-million-to-expand-patent-portfolio-in-age-related-and-neurodegenerative-diseases 2026-06-27T00:09:32+00:00 hourly 0.9 https://trial.medpath.com/news/beyond-air-reports-107-revenue-growth-awaits-fda-decision-on-second-generation-lungfit-ph-system 2026-06-26T23:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/pennsylvania-hospital-inspection-reports-tracking-safety-compliance-at-chestnut-hill-and-paoli-hospitals 2026-06-26T23:09:43+00:00 hourly 0.9 https://trial.medpath.com/news/snap-ceo-evan-spiegel-and-miranda-kerr-help-erase-550-million-in-medical-debt-for-over-261000-californians 2026-06-26T23:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/california-legislature-passes-sb-936-to-restrict-nitrous-oxide-sales-amid-rising-recreational-abuse 2026-06-26T22:09:21+00:00 hourly 0.9 https://trial.medpath.com/news/li-fraumeni-syndrome-the-tp53-mutation-that-confers-nearly-100-lifetime-cancer-risk 2026-06-26T22:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/csl-faces-dual-regulatory-headwinds-ema-recommends-tavneos-withdrawal-as-eu-opens-sanofi-flu-vaccine-probe 2026-06-26T22:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/ai-therapy-chatbots-face-mounting-state-regulatory-scrutiny-as-pennsylvania-sues-character-ai-over-unauthorized-practice-of-medicine 2026-06-26T22:08:44+00:00 hourly 0.9 https://trial.medpath.com/news/fda-issues-complete-response-letter-for-lantheus-lnth-2501-pet-diagnostic-kit-citing-third-party-manufacturing-issues 2026-06-26T22:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/ctdna-guided-adjuvant-therapy-in-colorectal-cancer-bespoke-crc-and-the-promise-of-next-generation-drugs 2026-06-26T22:08:29+00:00 hourly 0.9 https://trial.medpath.com/news/himalaya-trial-tremelimumab-plus-durvalumab-establishes-new-frontline-standard-in-unresectable-hepatocellular-carcinoma 2026-06-26T22:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/generative-ai-clinical-decision-support-shows-safety-and-documentation-gains-but-no-significant-reduction-in-treatment-failure-in-kenyan-primary-care-trial 2026-06-26T21:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/mexico-cuts-clinical-trial-approval-times-from-120-to-30-days-unlocking-us-643-million-in-pharma-investment 2026-06-26T21:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/fda-issues-complete-response-letter-for-sobi-s-gout-therapy-nasp-citing-manufacturing-issues-only 2026-06-26T20:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/sanofi-pasteur-secures-10-6-million-rise-pa-grant-to-decarbonize-swiftwater-vaccine-manufacturing-facility 2026-06-26T20:07:57+00:00 hourly 0.9 https://trial.medpath.com/news/longevity-biomarkers-move-from-wellness-trend-to-precision-medicine-experts-chart-the-future-of-proactive-health 2026-06-26T20:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/india-proposes-elimination-of-import-license-requirement-for-preclinical-drug-testing-to-boost-r-d 2026-06-26T20:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/swiss-pharma-faces-potential-us-section-301-trade-investigation-over-drug-pricing-policies 2026-06-26T20:07:17+00:00 hourly 0.9 https://trial.medpath.com/news/moderna-and-merck-s-personalized-cancer-vaccine-shows-positive-results-in-late-stage-trial 2026-06-26T19:07:08+00:00 hourly 0.9 https://trial.medpath.com/news/enhanced-games-parent-posts-60-million-loss-despite-billion-interaction-social-media-reach 2026-06-26T18:49:00+00:00 hourly 0.9 https://trial.medpath.com/news/immersive-vr-with-synchronous-neurostimulation-outperforms-conventional-rehabilitation-in-chronic-stroke-trial 2026-06-26T18:08:09+00:00 hourly 0.9 https://trial.medpath.com/news/aethlon-medical-identifies-novel-long-covid-biomarker-strengthening-rationale-for-hemopurifier-r-platform 2026-06-26T18:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/acadia-s-daybue-wins-eu-regulatory-backing-for-rett-syndrome-after-re-examination 2026-06-26T17:12:10+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-full-approval-to-laverdia-first-oral-at-home-treatment-for-canine-lymphoma 2026-06-26T17:11:17+00:00 hourly 0.9 https://trial.medpath.com/news/campbell-s-pharmacy-in-portrush-expands-clinical-services-with-robotic-dispensing-and-pharmacist-recruitment 2026-06-26T17:10:49+00:00 hourly 0.9 https://trial.medpath.com/news/apda-survey-reveals-widespread-funding-disruptions-in-parkinson-s-research-prompting-bridge-funding-program 2026-06-26T17:10:24+00:00 hourly 0.9 https://trial.medpath.com/news/zelluna-closes-uv1-cancer-vaccine-programme-after-fifth-phase-ii-trial-failure-in-ovarian-cancer 2026-06-26T17:09:54+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-receptor-agonists-linked-to-altered-smell-and-taste-in-type-2-diabetes-patients-large-scale-analysis-finds 2026-06-26T17:08:50+00:00 hourly 0.9 https://trial.medpath.com/news/spermidine-supplement-shows-promise-in-boosting-covid-19-vaccine-response-in-older-adults 2026-06-26T17:08:42+00:00 hourly 0.9 https://trial.medpath.com/news/china-overhauls-cosmetic-new-ingredient-regulations-to-spur-innovation-and-reduce-industry-burden 2026-06-26T17:08:38+00:00 hourly 0.9 https://trial.medpath.com/news/costco-and-scan-group-partner-to-launch-costco-branded-medicare-advantage-plan 2026-06-26T16:14:00+00:00 hourly 0.9 https://trial.medpath.com/news/ema-rejects-omeros-narsoplimab-for-stem-cell-transplant-complication-citing-insufficient-efficacy-data 2026-06-26T16:10:46+00:00 hourly 0.9 https://trial.medpath.com/news/epigenetic-editing-enters-the-clinic-first-trial-data-and-a-pipeline-poised-to-redefine-gene-therapy 2026-06-26T16:10:33+00:00 hourly 0.9 https://trial.medpath.com/news/curis-opens-eleven-clinical-sites-for-phase-2-takeaim-cll-study-of-emavusertib-zanubrutinib-combination 2026-06-26T15:09:52+00:00 hourly 0.9 https://trial.medpath.com/news/four-years-after-dobbs-abortion-numbers-surpass-pre-roe-levels-as-public-opinion-undergoes-historic-realignment 2026-06-26T13:12:00+00:00 hourly 0.9 https://trial.medpath.com/news/pioneering-crispr-gene-therapy-for-ctla-4-insufficiency-advances-toward-first-in-human-trial 2026-06-26T13:10:36+00:00 hourly 0.9 https://trial.medpath.com/news/elixirgen-therapeutics-and-nippon-shinyaku-enter-option-agreement-for-full-length-dystrophin-mrna-therapy-exg-7001-in-duchenne-muscular-dystrophy 2026-06-26T13:10:02+00:00 hourly 0.9 https://trial.medpath.com/news/network-medicine-framework-identifies-existing-drugs-that-could-be-repurposed-to-target-hallmarks-of-aging 2026-06-26T13:09:56+00:00 hourly 0.9 https://trial.medpath.com/news/smart-nanoplatform-uses-wound-acidity-to-trigger-accelerated-healing 2026-06-26T11:44:00+00:00 hourly 0.9 https://trial.medpath.com/news/sarcopenia-identified-as-key-predictor-of-immunotherapy-outcomes-in-advanced-nsclc 2026-06-26T06:05:37+00:00 hourly 0.9 https://trial.medpath.com/news/foley-hoag-announces-cell-gene-therapy-summit-2026 2026-06-26T05:07:45+00:00 hourly 0.9 https://trial.medpath.com/news/precigen-cfo-sells-1-1-million-in-shares-amid-stock-surge-and-fda-orphan-drug-designation-for-papzimeos 2026-06-26T05:02:00+00:00 hourly 0.9 https://trial.medpath.com/news/gilead-charts-path-to-top-5-oncology-company-through-adc-and-car-t-expansion 2026-06-26T03:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/everest-medicines-lerochol-bla-accepted-by-china-nmpa-for-hypercholesterolemia 2026-06-26T03:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/marquis-who-s-who-recognizes-shawn-patrick-o-brien-for-four-decades-of-pharmaceutical-leadership 2026-06-26T03:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-india-reports-16-6-profit-rise-in-q1fy26-driven-by-revenue-growth-and-margin-expansion 2026-06-26T03:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/first-commercially-sponsored-clinical-trial-in-regional-western-australia-targets-chemotherapy-induced-nausea 2026-06-26T00:08:44+00:00 hourly 0.9 https://trial.medpath.com/news/medical-ai-models-expose-rare-disease-and-minority-patients-to-privacy-attacks-nature-study-warns 2026-06-26T00:08:43+00:00 hourly 0.9 https://trial.medpath.com/news/vorasidenib-offers-targeted-treatment-for-idh-mutant-low-grade-gliomas 2026-06-26T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/larimar-therapeutics-faces-securities-investigation-after-anaphylaxis-safety-signal-emerges-in-nomlabofusp-trials-for-friedreich-s-ataxia 2026-06-25T23:36:00+00:00 hourly 0.9 https://trial.medpath.com/news/nrx-pharmaceuticals-and-kadima-neuropsychiatry-institute-clash-over-failed-acquisition-arbitration-and-scientific-direction 2026-06-25T22:10:22+00:00 hourly 0.9 https://trial.medpath.com/news/rapid-whole-genome-sequencing-cuts-severe-neonatal-rare-disease-diagnosis-from-5-years-to-5-5-days 2026-06-25T22:10:21+00:00 hourly 0.9 https://trial.medpath.com/news/how-a-bacterial-survival-strategy-is-changing-medicine-baylor-team-uncovers-antibiotic-persistence-mechanism 2026-06-25T22:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/medication-adherence-in-copd-cost-barriers-and-strategies-for-affordability-on-fixed-incomes 2026-06-25T21:09:00+00:00 hourly 0.9 https://trial.medpath.com/news/experts-call-for-who-to-recognize-ocular-toxoplasmosis-as-a-neglected-tropical-disease 2026-06-25T21:08:36+00:00 hourly 0.9 https://trial.medpath.com/news/updoc-debuts-first-fda-cleared-agentic-clinical-ai-platform-for-real-time-patient-care 2026-06-25T21:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/medicare-proposes-33-4-cut-to-hospital-reimbursement-for-340b-drugs-sparking-safety-net-hospital-backlash 2026-06-25T21:07:48+00:00 hourly 0.9 https://trial.medpath.com/news/updated-nccn-guidelines-expand-mental-health-screening-to-improve-cancer-survivorship-care 2026-06-25T21:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/texas-appeals-court-signals-j-j-and-kenvue-may-be-dismissed-from-tylenol-autism-lawsuit 2026-06-25T21:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/ucla-team-awarded-7-49-million-cirm-grant-to-develop-off-the-shelf-car-nkt-cell-therapy-for-multiple-sclerosis 2026-06-25T20:09:40+00:00 hourly 0.9 https://trial.medpath.com/news/nih-awards-321589-to-rowan-university-for-parkinson-s-disease-research-on-aerodigestive-dysfunction 2026-06-25T19:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-receptor-agonists-linked-to-increased-risk-of-smell-and-taste-disturbances-study-finds 2026-06-25T19:08:49+00:00 hourly 0.9 https://trial.medpath.com/news/trem-1-emerges-as-master-amplifier-of-inflammation-offering-new-therapeutic-avenue-for-sepsis-arthritis-and-neurodegenerative-diseases 2026-06-25T19:08:44+00:00 hourly 0.9 https://trial.medpath.com/news/onco-doac-bleed-score-new-risk-stratification-tool-for-bleeding-risk-in-cancer-associated-vte-patients-on-doacs 2026-06-25T19:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/could-a-simple-breath-test-detect-diabetes-before-symptoms-appear 2026-06-25T19:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/attunio-health-expands-ai-powered-precision-psychiatry-platform-with-quest-diagnostics-and-getlabs 2026-06-25T19:08:18+00:00 hourly 0.9 https://trial.medpath.com/news/imcd-opens-state-of-the-art-pharmaceutical-technical-centre-in-new-jersey 2026-06-25T18:07:30+00:00 hourly 0.9 https://trial.medpath.com/news/patient-portal-messaging-surges-153-since-2020-reshaping-us-healthcare-delivery 2026-06-25T18:06:39+00:00 hourly 0.9 https://trial.medpath.com/news/abo-101-gene-editing-therapy-for-primary-hyperoxaluria-type-1-granted-orphan-drug-designation-by-european-commission 2026-06-25T18:06:17+00:00 hourly 0.9 https://trial.medpath.com/news/prostate-cancer-cases-rising-3-annually-as-experts-renew-debate-over-psa-screening 2026-06-25T17:11:39+00:00 hourly 0.9 https://trial.medpath.com/news/u-s-launch-prices-for-new-drugs-fell-in-2025-as-fewer-costly-gene-therapies-reached-market 2026-06-25T17:11:17+00:00 hourly 0.9 https://trial.medpath.com/news/chan-zuckerberg-biohub-opens-fourth-rare-as-one-funding-round-expands-ai-powered-drug-repurposing-partnership-with-every-cure 2026-06-25T17:10:12+00:00 hourly 0.9 https://trial.medpath.com/news/global-proteins-protein-crystals-market-projected-to-reach-960-billion-by-2030-driven-by-biopharmaceutical-r-d-and-structural-biology-advances 2026-06-25T17:10:07+00:00 hourly 0.9 https://trial.medpath.com/news/aston-university-leads-eur1-2m-european-project-to-develop-living-magnetobots-for-targeted-cancer-theranostics 2026-06-25T17:09:42+00:00 hourly 0.9 https://trial.medpath.com/news/legacy-ultrasound-cybersecurity-framework-90-of-cleared-systems-predate-us-cyber-device-statute 2026-06-25T17:08:05+00:00 hourly 0.9 https://trial.medpath.com/news/vaccine-adjuvants-market-projected-to-reach-usd-6-19-billion-by-2035-driven-by-mrna-and-oncology-vaccine-innovation 2026-06-25T17:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/aidoc-receives-fda-breakthrough-device-designation-for-ai-that-drafts-radiology-reports 2026-06-25T17:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/biomarkers-reveal-immune-overactivity-not-exhaustion-drives-chronic-critical-illness-in-trauma-patients 2026-06-25T17:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/nanomedicine-strategies-for-remodeling-the-solid-tumor-microenvironment-stromal-targeting-hypoxia-modulation-and-photodynamic-immunotherapy 2026-06-25T17:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/planned-parenthood-to-reopen-in-new-orleans-with-non-abortion-health-services-marking-partial-return-to-louisiana 2026-06-25T17:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/navi-teen-co-designed-digital-wellness-app-launches-statewide-in-new-mexico-to-address-youth-mental-health-crisis 2026-06-25T16:28:00+00:00 hourly 0.9 https://trial.medpath.com/news/novakand-pharma-pivots-to-orphan-drug-development-for-treatment-resistant-ovarian-cancer-and-leukemia 2026-06-25T16:09:11+00:00 hourly 0.9 https://trial.medpath.com/news/asco-living-guideline-adds-repotrectinib-and-zongertinib-for-advanced-nsclc-with-driver-alterations 2026-06-25T16:08:05+00:00 hourly 0.9 https://trial.medpath.com/news/evaluate-s-ask-ella-wins-enterprise-ai-search-solution-of-the-year-at-2026-ai-breakthrough-awards 2026-06-25T16:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/ai-is-reshaping-how-doctors-train-and-what-they-become 2026-06-25T16:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/vhio-renews-severo-ochoa-centre-of-excellence-accreditation-with-near-perfect-score 2026-06-25T15:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-weight-loss-boom-creates-tissue-restoration-gap-as-conexeu-advances-regenerative-platform-toward-2027-fda-submission 2026-06-25T15:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/eu-funds-first-randomized-phage-therapy-trial-with-eur15-million-to-combat-recurrent-utis 2026-06-25T15:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/massive-plasma-metabolite-atlas-maps-blood-chemistry-to-hundreds-of-diseases-in-390000-individuals 2026-06-25T15:07:01+00:00 hourly 0.9 https://trial.medpath.com/news/drug-repurposing-screen-identifies-70-existing-compounds-including-beta-lactam-antibiotics-that-block-deadly-hantavirus-infections 2026-06-25T15:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/ai-and-real-world-data-are-turning-the-promise-of-precision-medicine-into-clinical-reality 2026-06-25T15:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/aecc-awards-eur7-35-million-to-61-madrid-cancer-research-projects-cnio-secures-over-eur3-million 2026-06-25T15:06:31+00:00 hourly 0.9 https://trial.medpath.com/news/kite-and-american-cancer-society-renew-partnership-to-close-car-t-cell-therapy-access-gap-for-blood-cancer-patients 2026-06-25T15:06:29+00:00 hourly 0.9 https://trial.medpath.com/news/greenstone-biosciences-awarded-breakthrough-t1d-grant-to-build-a-t1d-derived-islet-cell-platform 2026-06-25T15:06:28+00:00 hourly 0.9 https://trial.medpath.com/news/new-national-recommendations-and-nice-quality-standard-aim-to-transform-rare-disease-care 2026-06-25T14:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/cord-blood-biomarkers-show-promise-for-early-risk-stratification-in-neonatal-encephalopathy-meta-analysis-finds 2026-06-25T13:09:18+00:00 hourly 0.9 https://trial.medpath.com/news/germany-s-merck-kgaa-to-acquire-bio-techne-in-11-3-billion-life-sciences-mega-deal 2026-06-25T13:09:16+00:00 hourly 0.9 https://trial.medpath.com/news/rewiring-car-t-cell-signaling-plat-chimeric-switch-converts-pd-1-inhibition-into-t-cell-activation 2026-06-25T13:09:08+00:00 hourly 0.9 https://trial.medpath.com/news/shaanxi-micot-advances-first-in-class-dual-target-anticoagulant-mt1002-into-phase-ii-hemodialysis-trial 2026-06-25T13:09:01+00:00 hourly 0.9 https://trial.medpath.com/news/minaris-and-bionova-scientific-partner-to-expand-plasmid-dna-supply-for-cell-and-gene-therapy-manufacturing 2026-06-25T13:08:44+00:00 hourly 0.9 https://trial.medpath.com/news/racura-oncology-doses-first-patient-in-phase-1-harness-1-trial-of-rc220-for-egfr-mutant-nsclc 2026-06-25T13:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/cstone-strikes-oceania-deal-with-arrotex-for-anti-pd-l1-antibody-sugemalimab 2026-06-25T13:08:36+00:00 hourly 0.9 https://trial.medpath.com/news/global-bone-densitometers-market-to-reach-usd-584-8-million-by-2036-driven-by-value-based-care-and-enterprise-imaging-integration 2026-06-25T13:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/a-geroprotective-probiotic-and-its-functional-metabolite-counteract-inflammaging-to-extend-healthspan 2026-06-25T12:08:16+00:00 hourly 0.9 https://trial.medpath.com/news/embarc-and-insmed-announce-landmark-3000-patient-study-to-evaluate-whether-brensocatib-can-modify-the-course-of-bronchiectasis 2026-06-25T12:07:17+00:00 hourly 0.9 https://trial.medpath.com/news/c-ray-therapeutics-secures-radiopharmaceutical-production-license-in-china-bolstering-crdmo-capabilities 2026-06-25T12:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/decentralised-trials-in-apac-why-the-frontier-hasn-t-arrived-and-what-it-will-take 2026-06-25T11:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/civicascript-s-nonprofit-model-delivers-16-million-in-generic-drug-savings-in-2025-cumulative-savings-reach-44-million 2026-06-25T11:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/western-nevada-college-students-advance-biomedical-research-through-nih-funded-inbre-program 2026-06-25T11:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/mesoblast-draws-us-50-million-from-five-year-non-dilutive-facility-to-strengthen-balance-sheet-and-retire-high-cost-debt 2026-06-25T11:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/sujini-ponnusamy-pioneering-the-convergence-of-ai-and-genomics-in-precision-oncology 2026-06-25T11:07:28+00:00 hourly 0.9 https://trial.medpath.com/news/how-peacemaker-immune-cells-could-unlock-long-term-disease-remission-across-autoimmunity-and-beyond 2026-06-25T11:07:02+00:00 hourly 0.9 https://trial.medpath.com/news/proposed-federal-rule-threatens-to-politicize-nih-grantmaking-sparking-bipartisan-alarm-in-biomedical-research-community 2026-06-25T11:06:39+00:00 hourly 0.9 https://trial.medpath.com/news/college-students-in-mental-health-crisis-are-increasingly-turning-to-unregulated-ai-for-support-study-finds 2026-06-25T09:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/crism-therapeutics-advances-toward-patient-recruitment-for-phase-ii-glioblastoma-trial-of-irinotecan-chemoseed 2026-06-25T08:09:41+00:00 hourly 0.9 https://trial.medpath.com/news/innovative-molecules-doses-first-patient-in-phase-2a-trial-of-helicase-primase-inhibitor-adibelivir-for-recurrent-genital-herpes 2026-06-25T08:08:39+00:00 hourly 0.9 https://trial.medpath.com/news/the-splice-of-life-how-alternative-splicing-is-reshaping-the-therapeutic-landscape-across-rare-diseases-and-oncology 2026-06-25T08:08:32+00:00 hourly 0.9 https://trial.medpath.com/news/johnson-johnson-poised-to-cross-100-billion-revenue-milestone-amid-patent-cliff-navigation 2026-06-25T08:08:31+00:00 hourly 0.9 https://trial.medpath.com/news/choroidal-medium-large-vascular-index-identified-as-optimal-oct-a-biomarker-for-thyroid-eye-disease-activity 2026-06-25T08:08:28+00:00 hourly 0.9 https://trial.medpath.com/news/royalty-pharma-opens-first-asia-pacific-base-in-hong-kong-as-chinese-biotech-out-licensing-deals-surge 2026-06-25T06:08:44+00:00 hourly 0.9 https://trial.medpath.com/news/liposomal-nanoparticulate-drug-delivery-systems-engineering-membrane-destabilization-for-precision-nanomedicine 2026-06-25T05:30:00+00:00 hourly 0.9 https://trial.medpath.com/news/new-mexico-governor-demands-criminal-probe-of-dea-over-fentanyl-shipments-allowed-to-reach-streets 2026-06-25T05:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/hydrogels-in-autoimmune-disease-from-passive-carriers-to-active-immune-regulation-platforms 2026-06-25T05:07:48+00:00 hourly 0.9 https://trial.medpath.com/news/policy-talent-and-innovation-are-fueling-pennsylvania-s-life-sciences-growth 2026-06-25T04:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/shapiro-administration-proposes-900000-food-is-medicine-pilot-to-provide-medically-tailored-meals-for-medicaid-recipients 2026-06-25T03:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-testing-expansion-poised-to-dramatically-increase-demand-for-als-specialist-care-across-the-united-states 2026-06-25T02:54:00+00:00 hourly 0.9 https://trial.medpath.com/news/heavy-alcohol-use-may-accelerate-brain-aging-and-alzheimer-s-pathology-through-distinct-biological-mechanisms-animal-studies-suggest 2026-06-25T01:21:00+00:00 hourly 0.9 https://trial.medpath.com/news/cleveland-clinic-launches-multidisciplinary-initiative-to-advance-igg4-related-disease-diagnosis-research-and-care 2026-06-25T01:06:22+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-testing-in-reproductive-medicine-advancing-diagnosis-of-male-and-female-infertility 2026-06-25T01:06:14+00:00 hourly 0.9 https://trial.medpath.com/news/ghrelin-receptor-agonist-ac01-shows-safety-and-hemodynamic-promise-in-early-heart-failure-trial 2026-06-25T00:08:11+00:00 hourly 0.9 https://trial.medpath.com/news/epicrispr-s-epi-321-reaches-full-enrolment-in-first-in-human-epigenetic-crispr-therapy-trial 2026-06-25T00:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/prescient-s-first-in-class-ggtase-1-inhibitor-ptx-100-accelerates-toward-pivotal-phase-2-milestones-in-ctcl 2026-06-25T00:07:48+00:00 hourly 0.9 https://trial.medpath.com/news/telehealth-platforms-launch-structured-virtual-tirzepatide-assessment-programs-for-weight-management 2026-06-25T00:05:00+00:00 hourly 0.9 https://trial.medpath.com/news/dr-christina-rahm-and-drc-ventures-win-gold-stevie-award-for-patent-driven-manufacturing-innovation 2026-06-24T23:06:50+00:00 hourly 0.9 https://trial.medpath.com/news/radioligand-therapy-a-30-billion-cancer-breakthrough-faces-geopolitical-headwinds 2026-06-24T23:06:27+00:00 hourly 0.9 https://trial.medpath.com/news/exozymes-secures-2-million-nih-grant-to-advance-cannabinoid-analogs-for-drug-discovery 2026-06-24T22:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-patents-and-africa-the-covid-19-lessons-we-still-have-not-learned 2026-06-24T22:08:28+00:00 hourly 0.9 https://trial.medpath.com/news/calcimedica-s-auxora-clears-fda-safety-review-kourage-trial-in-aki-to-resume-dosing 2026-06-24T22:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/department-of-health-abu-dhabi-and-children-s-hospital-of-philadelphia-launch-strategic-collaboration-to-advance-gene-editing-for-rare-diseases 2026-06-24T22:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/tobacco-free-nicotine-products-why-tobacco-free-does-not-mean-risk-free 2026-06-24T22:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/botanicure-s-botanical-drug-bota-ns1-shows-early-promise-for-cognitive-decline-in-pilot-study 2026-06-24T21:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/pfizer-declares-0-43-third-quarter-2026-dividend-marking-351st-consecutive-quarterly-payout 2026-06-24T21:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/houston-methodist-receives-110-million-donation-largest-in-health-system-s-107-year-history 2026-06-24T21:07:30+00:00 hourly 0.9 https://trial.medpath.com/news/canadian-patients-and-advocacy-groups-escalate-pressure-to-fund-ovarian-cancer-drug-elahere-after-negotiations-collapse 2026-06-24T21:07:27+00:00 hourly 0.9 https://trial.medpath.com/news/msu-researchers-uncover-how-ovarian-cancer-resists-chemotherapy-and-how-to-reverse-it 2026-06-24T21:07:06+00:00 hourly 0.9 https://trial.medpath.com/news/how-decentralized-clinical-trials-are-reshaping-patient-recruitment-and-advancing-health-equity 2026-06-24T21:07:01+00:00 hourly 0.9 https://trial.medpath.com/news/advancing-global-genomic-equity-the-case-for-national-genome-projects-in-africa 2026-06-24T20:09:52+00:00 hourly 0.9 https://trial.medpath.com/news/yale-study-reveals-gut-based-iga-immunity-as-key-to-future-norovirus-vaccines-and-treatments 2026-06-24T20:08:42+00:00 hourly 0.9 https://trial.medpath.com/news/chop-researchers-develop-nanoparticle-platform-to-accelerate-cancer-immunotherapy-screening 2026-06-24T19:08:50+00:00 hourly 0.9 https://trial.medpath.com/news/rare-histological-subtypes-of-triple-negative-breast-cancer-a-comprehensive-review-highlights-diagnostic-and-therapeutic-implications 2026-06-24T19:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/jane-coffin-childs-fund-names-32-postdoctoral-fellows-for-2026-committing-nearly-9-million-to-early-career-biomedical-research 2026-06-24T19:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/dea-to-present-testimony-on-medical-marijuana-benefits-in-rescheduling-hearing-as-opponents-push-harms-narrative 2026-06-24T19:07:46+00:00 hourly 0.9 https://trial.medpath.com/news/boron-based-nanostructure-delivers-sugars-directly-into-cells-without-toxic-solvents 2026-06-24T18:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/laboratory-beagles-may-bridge-the-autism-drug-discovery-gap-new-perspective-argues 2026-06-24T18:08:25+00:00 hourly 0.9 https://trial.medpath.com/news/medicare-part-a-trust-fund-depletion-projected-for-q2-2033-one-quarter-earlier-than-prior-estimate 2026-06-24T18:08:05+00:00 hourly 0.9 https://trial.medpath.com/news/v-synthes2-enables-physics-based-virtual-screening-of-36-billion-compounds-for-challenging-drug-targets 2026-06-24T18:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/sponsors-urged-to-drop-qes-everywhere-default-in-global-trials-adopt-four-dimension-consent-framework 2026-06-24T18:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/france-confirms-first-ebola-case-outside-africa-in-drc-bundibugyo-outbreak-as-un-warns-of-unprecedented-spread 2026-06-24T18:07:53+00:00 hourly 0.9 https://trial.medpath.com/news/danaher-s-masimo-acquisition-and-biotech-guidance-cut-a-tale-of-two-catalysts 2026-06-24T17:49:00+00:00 hourly 0.9 https://trial.medpath.com/news/metabolon-delivers-landmark-metabolomics-dataset-from-7500-participants-to-genomics-england-s-100000-genomes-project 2026-06-24T17:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/deep-learning-identifies-novel-ecg-biomarker-for-sudden-cardiac-death-published-in-nature 2026-06-24T17:08:59+00:00 hourly 0.9 https://trial.medpath.com/news/fda-complete-response-letters-how-crls-reshape-biotech-valuations-and-drug-development-timelines 2026-06-24T17:08:57+00:00 hourly 0.9 https://trial.medpath.com/news/africa-launches-continental-biotech-database-to-streamline-regulatory-access-and-boost-agricultural-biotechnology 2026-06-24T17:08:49+00:00 hourly 0.9 https://trial.medpath.com/news/wearable-devices-detect-cytokine-release-syndrome-7-hours-earlier-in-car-t-recipients-pilot-study-shows 2026-06-24T17:08:05+00:00 hourly 0.9 https://trial.medpath.com/news/first-sars-cov-2-exposure-shapes-igg-subclass-switching-and-breakthrough-infection-risk-after-mrna-vaccination 2026-06-24T17:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/celecor-completes-fda-submission-for-zalunfiban-a-first-point-of-care-antiplatelet-for-stemi-heart-attacks 2026-06-24T16:09:07+00:00 hourly 0.9 https://trial.medpath.com/news/institute-for-autism-research-relocates-to-university-at-buffalo-with-450000-grant-expanding-access-to-evidence-based-social-skills-programs 2026-06-24T16:09:04+00:00 hourly 0.9 https://trial.medpath.com/news/stripe-anthropic-and-openai-back-500-million-intercept-fund-to-eliminate-respiratory-viruses 2026-06-24T16:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/sangamo-therapeutics-files-for-chapter-11-bankruptcy-eli-lilly-and-astellas-positioned-as-lead-bidders-for-key-assets 2026-06-24T16:08:35+00:00 hourly 0.9 https://trial.medpath.com/news/nature-medicine-retracts-controversial-phase-3-trial-on-time-of-day-immunochemotherapy-in-nsclc 2026-06-24T16:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/megacluster-of-antibiotic-genes-discovered-in-soil-bacteria-targets-biotin-pathway-to-combat-superbugs 2026-06-24T16:08:29+00:00 hourly 0.9 https://trial.medpath.com/news/investigational-ctsa-inhibitor-offers-new-pathway-for-cholesterol-control-study-in-nature-reveals 2026-06-24T16:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/hkeybio-launches-hkey-exetm-1-0-preclinical-framework-to-accelerate-drug-development-for-eosinophilic-gastrointestinal-disorders 2026-06-24T15:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/reprocell-submits-application-for-stem-cell-therapy-stemchymal-in-japan-for-spinocerebellar-ataxia-sca3-and-sca6 2026-06-24T15:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/ehu-researchers-develop-novel-metabolomics-protocol-to-identify-sperm-biomarkers-for-male-infertility-diagnosis 2026-06-24T14:10:32+00:00 hourly 0.9 https://trial.medpath.com/news/imbria-s-ninerafaxstat-wins-fda-orphan-drug-designation-for-non-obstructive-hypertrophic-cardiomyopathy 2026-06-24T14:09:52+00:00 hourly 0.9 https://trial.medpath.com/news/ollin-biosciences-secures-330m-series-b-to-advance-vabysmo-challenger-into-phase-3-trials 2026-06-24T14:09:48+00:00 hourly 0.9 https://trial.medpath.com/news/alzpath-signs-global-licensing-agreement-with-abbott-to-advance-blood-based-alzheimer-s-disease-testing 2026-06-24T14:09:41+00:00 hourly 0.9 https://trial.medpath.com/news/cambridge-researchers-identify-three-distinct-biological-subtypes-of-severe-pneumonia-explaining-variable-icu-outcomes 2026-06-24T14:08:38+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-and-becoming-rentable-partner-to-expand-accessible-short-term-rentals-for-the-sma-community 2026-06-24T14:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/waters-and-imu-biosciences-forge-strategic-partnership-to-scale-ai-powered-immune-mapping-platform 2026-06-24T14:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/hidden-lung-specific-dpp9-protein-variant-linked-to-severe-covid-19-and-lung-fibrosis 2026-06-24T13:38:00+00:00 hourly 0.9 https://trial.medpath.com/news/biocon-and-duopharma-biotech-secure-over-myr-225-million-in-insulin-contracts-from-malaysia-s-ministry-of-health 2026-06-24T13:06:41+00:00 hourly 0.9 https://trial.medpath.com/news/antares-therapeutics-signs-potential-1-9-billion-deal-with-novartis-to-target-undruggable-oncology-proteins 2026-06-24T13:06:34+00:00 hourly 0.9 https://trial.medpath.com/news/60-years-of-austrian-newborn-screening-early-detection-transforming-outcomes-for-thousands-of-children 2026-06-24T12:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/thalia-acquires-sanmirna-secures-ps2-75m-to-advance-anti-mirna-therapy-for-aml 2026-06-24T12:09:16+00:00 hourly 0.9 https://trial.medpath.com/news/hierarchical-endpoints-and-win-statistics-a-paradigm-shift-for-geromedicine-clinical-trials 2026-06-24T12:09:09+00:00 hourly 0.9 https://trial.medpath.com/news/pharmacovigilance-automation-market-to-reach-usd-5-25-billion-by-2035-driven-by-ai-and-nlp-adoption 2026-06-24T12:09:00+00:00 hourly 0.9 https://trial.medpath.com/news/pet-imaging-moves-beyond-diagnosis-to-prognostic-and-predictive-applications-in-precision-oncology 2026-06-24T11:07:21+00:00 hourly 0.9 https://trial.medpath.com/news/microbiome-therapeutics-market-poised-to-surge-from-288-8m-to-4b-by-2034-driven-by-defined-consortia-and-immuno-oncology-innovations 2026-06-24T11:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/everest-medicines-and-hainan-herui-forge-commercialization-partnership-for-budesonide-enteric-capsules-in-china 2026-06-24T11:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/immunotherapy-with-rituximab-may-temporarily-restore-fertility-in-autoimmune-premature-ovarian-insufficiency 2026-06-24T11:06:49+00:00 hourly 0.9 https://trial.medpath.com/news/aacr-cancer-disparities-progress-report-2026-reveals-narrowing-gaps-but-persistent-inequities-across-u-s-populations 2026-06-24T10:06:18+00:00 hourly 0.9 https://trial.medpath.com/news/tesamorelin-the-fda-approved-ghrh-analog-bridging-clinical-certainty-and-research-frontiers 2026-06-24T10:06:15+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-premarket-approval-to-hepquant-shunt-liver-diagnostic-test-for-compensated-cirrhosis 2026-06-24T09:09:05+00:00 hourly 0.9 https://trial.medpath.com/news/doj-s-2026-health-care-fraud-takedown-455-charged-6-5-billion-in-alleged-false-claims-signals-new-era-of-data-driven-enforcement 2026-06-24T09:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/rq-bio-secures-115-million-series-a-to-advance-long-acting-antibody-rqb01-for-full-season-influenza-prevention 2026-06-24T09:08:42+00:00 hourly 0.9 https://trial.medpath.com/news/extracellular-vesicles-as-next-generation-therapeutics-global-pipeline-regulatory-landscape-and-translational-challenges 2026-06-24T09:08:08+00:00 hourly 0.9 https://trial.medpath.com/news/gata6-loss-unlocks-a-hidden-switch-driving-colorectal-cancer-liver-metastasis 2026-06-24T09:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/phathom-completes-enrollment-ahead-of-schedule-in-landmark-phase-2-trial-of-vonoprazan-for-eosinophilic-esophagitis 2026-06-24T09:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/federal-circuit-rules-typographical-error-in-provisional-application-spoils-priority-date-invalidating-enanta-patent-against-pfizer-s-paxlovid 2026-06-24T08:07:32+00:00 hourly 0.9 https://trial.medpath.com/news/first-hand-account-chemotherapy-and-immunotherapy-infusion-begins-at-queen-s-cancer-center 2026-06-24T08:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/florida-attorney-general-launches-anticompetitive-investigation-into-cvs-caremark-over-pharmacy-practices 2026-06-24T08:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/biotech-etf-technical-analysis-ibb-and-pbe-show-strong-sentiment-across-all-horizons 2026-06-24T08:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/blow-fill-seal-technology-market-poised-to-reach-6-95-billion-by-2030-driven-by-sterile-pharmaceutical-packaging-demand 2026-06-24T07:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/voyageur-pharmaceuticals-engages-fluor-for-feasibility-studies-on-north-america-s-first-vertically-integrated-contrast-media-supply-chain 2026-06-24T07:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/netec-announces-second-round-of-nsps-level-2-stand-awards-expanding-special-pathogen-preparedness-to-75-u-s-facilities 2026-06-24T07:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/fda-clears-aft-pharmaceuticals-injectable-iron-project-to-proceed-to-global-phase-3-trial 2026-06-24T05:06:56+00:00 hourly 0.9 https://trial.medpath.com/news/israeli-patient-detoxes-from-130-pill-a-day-opioid-addiction-in-20-minutes-using-noninvasive-focused-ultrasound-neuromodulation 2026-06-24T05:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/neoadjuvant-immunotherapy-shows-promise-as-bridge-to-liver-transplant-in-hcc-but-rejection-risk-demands-caution 2026-06-24T03:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/prior-authorization-delays-linked-to-worsened-outcomes-in-neurological-diseases-study-finds 2026-06-24T02:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/corxel-s-oral-glp-1-agonist-cx11-achieves-up-to-11-5-weight-loss-in-u-s-phase-2-obesity-trial 2026-06-24T01:06:47+00:00 hourly 0.9 https://trial.medpath.com/news/grammy-winning-singer-muni-long-receives-life-saving-double-lung-transplant-after-one-week-prognosis 2026-06-24T01:06:41+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-t-cells-with-novel-pd-l1-specific-tcr-target-both-cancer-and-immunosuppressive-immune-cells 2026-06-24T01:06:03+00:00 hourly 0.9 https://trial.medpath.com/news/samsung-partners-with-alcedis-to-advance-clinical-research-using-wearable-based-endpoints 2026-06-24T00:08:02+00:00 hourly 0.9 https://trial.medpath.com/news/ups-invests-48-million-in-global-cold-chain-expansion-to-meet-surging-biologics-demand 2026-06-24T00:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/piezo1-the-mechanosensitive-ion-channel-at-the-crossroads-of-bone-health-and-orthopedic-disease 2026-06-24T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/the-lactate-lactylation-axis-in-tumor-radioresistance-from-metabolic-adaptation-to-therapeutic-targeting 2026-06-24T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/gaba-immune-pathway-drives-sex-specific-glioblastoma-growth-in-females-study-finds 2026-06-23T23:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/coherus-and-zumutor-launch-phase-1-trial-of-nk-checkpoint-antibody-zm008-combined-with-pd-1-inhibitor-loqtorzi-in-solid-tumors 2026-06-23T23:06:06+00:00 hourly 0.9 https://trial.medpath.com/news/market-rotation-fuels-biotech-surge-as-ai-trade-falters-definium-therapeutics-rises-on-anxiety-disorder-catalyst 2026-06-23T23:05:53+00:00 hourly 0.9 https://trial.medpath.com/news/pathway-labs-echonext-receives-world-s-first-fda-clearance-for-ai-detection-of-hidden-structural-heart-disease-from-routine-ecgs 2026-06-23T22:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/zhenjiankang-medical-s-ipo-surge-how-a-percutaneous-surgical-robotics-pioneer-achieved-three-accelerations-in-eight-years 2026-06-23T22:07:45+00:00 hourly 0.9 https://trial.medpath.com/news/va-greater-los-angeles-healthcare-system-celebrates-national-va-research-week-2026-honors-pioneering-researchers 2026-06-23T22:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/agomab-unveils-design-for-first-ever-phase-2b-trial-in-fibrostenosing-crohn-s-disease-with-oral-alk5-inhibitor-ontunisertib 2026-06-23T21:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/mosquitoes-test-positive-for-west-nile-virus-in-bernalillo-county-new-mexico 2026-06-23T20:09:51+00:00 hourly 0.9 https://trial.medpath.com/news/slope-and-velocity-clinical-research-partner-to-standardize-inventory-management-across-70-sites 2026-06-23T20:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/tcr-engineered-t-cells-targeting-shared-b-catenin-mutation-eradicate-solid-tumors-earns-ous-research-prize 2026-06-23T19:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/personalized-medicine-in-oncology-experts-call-for-patient-centered-innovation-and-better-communication-at-islb-and-asco-meetings 2026-06-23T19:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/ftc-files-amicus-brief-supporting-antitrust-suit-against-johnson-johnson-over-stelara-monopoly 2026-06-23T19:07:18+00:00 hourly 0.9 https://trial.medpath.com/news/ucla-led-consortium-launches-billion-cellxcell-project-to-decode-cellular-communication-published-in-nature-biotechnology 2026-06-23T19:06:46+00:00 hourly 0.9 https://trial.medpath.com/news/seegnal-to-deploy-medication-safety-platform-at-nazareth-hospital-emms-targeting-alert-fatigue-in-clinical-prescribing 2026-06-23T18:12:58+00:00 hourly 0.9 https://trial.medpath.com/news/local-access-to-radiation-oncology-strengthens-cancer-care-in-the-quad-cities-as-iowa-faces-rising-cancer-rates 2026-06-23T18:12:40+00:00 hourly 0.9 https://trial.medpath.com/news/masshealth-to-end-glp-1-coverage-for-weight-loss-affecting-22000-patients 2026-06-23T18:12:25+00:00 hourly 0.9 https://trial.medpath.com/news/leal-therapeutics-secures-30-million-series-a-extension-and-initiates-phase-1b-2a-trial-of-ltx-001-in-schizophrenia 2026-06-23T18:12:25+00:00 hourly 0.9 https://trial.medpath.com/news/eli-lilly-dominates-q1-2025-branded-pharma-earnings-with-55-5-revenue-surge-merck-supernus-post-mixed-results 2026-06-23T18:12:08+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-canada-and-sp-quebec-mark-16-years-of-partnership-with-ms-tri-challenge-surpassing-650000-cad-in-fundraising 2026-06-23T18:11:32+00:00 hourly 0.9 https://trial.medpath.com/news/alteogen-signs-up-to-3-2-billion-option-and-licensing-deal-with-novartis-for-subcutaneous-formulations 2026-06-23T18:11:21+00:00 hourly 0.9 https://trial.medpath.com/news/whole-genome-sequencing-maps-rpob-mutations-that-predict-rifabutin-susceptibility-in-multidrug-resistant-tuberculosis 2026-06-23T18:10:38+00:00 hourly 0.9 https://trial.medpath.com/news/gene-therapy-developer-sangamo-therapeutics-files-for-chapter-11-bankruptcy-with-sale-plans 2026-06-23T18:10:21+00:00 hourly 0.9 https://trial.medpath.com/news/ichnos-glenmark-innovation-appoints-mariana-cota-stirner-as-chief-medical-officer-to-advance-multispecific-antibody-pipeline 2026-06-23T18:09:46+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-ide-approval-for-solenic-medical-s-sola-2-pivotal-trial-in-periprosthetic-joint-infections 2026-06-23T18:09:25+00:00 hourly 0.9 https://trial.medpath.com/news/veristat-bolsters-leadership-with-four-strategic-hires-to-accelerate-novel-therapy-approvals-in-cell-and-gene-therapy-oncology-and-rare-disease 2026-06-23T18:08:17+00:00 hourly 0.9 https://trial.medpath.com/news/meet-the-doctor-building-tiny-tools-for-big-science-breakthroughs-ucla-s-steven-jonas-on-nanotechnology-pediatric-cancer-and-the-future-of-cell-and-gene-therapy 2026-06-23T18:08:16+00:00 hourly 0.9 https://trial.medpath.com/news/unapproved-klotho-gene-therapy-for-longevity-set-to-launch-at-offshore-clinics-raising-safety-and-ethics-concerns 2026-06-23T18:08:12+00:00 hourly 0.9 https://trial.medpath.com/news/tetanus-cases-rise-in-the-u-s-amid-declining-vaccination-rates-cdc-reports-show 2026-06-23T17:06:31+00:00 hourly 0.9 https://trial.medpath.com/news/engaging-families-in-hie-research-a-call-to-action-for-neonatal-care-and-drug-development 2026-06-23T17:06:20+00:00 hourly 0.9 https://trial.medpath.com/news/cognivia-and-mayo-clinic-collaborate-to-advance-behavioral-intelligence-in-clinical-research-and-patient-care 2026-06-23T17:06:15+00:00 hourly 0.9 https://trial.medpath.com/news/uc-san-diego-researcher-wins-5-6m-nih-avant-garde-award-to-develop-ai-tools-for-hiv-hepatitis-c-and-overdose-prevention 2026-06-23T17:06:14+00:00 hourly 0.9 https://trial.medpath.com/news/europe-positions-itself-as-global-science-superpower-amid-us-research-turmoil 2026-06-23T16:09:58+00:00 hourly 0.9 https://trial.medpath.com/news/merck-launches-saturnus-bio-with-versant-ventures-in-50m-build-to-buy-deal-targeting-rare-genetic-cardiomyopathies 2026-06-23T16:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-fast-track-designation-to-biomendics-tolasure-gel-for-epidermolysis-bullosa-simplex 2026-06-23T16:08:15+00:00 hourly 0.9 https://trial.medpath.com/news/understanding-anthrax-expert-insights-on-transmission-treatment-and-prevention-of-a-persistent-zoonotic-threat 2026-06-23T16:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/canary-speech-launches-ai-powered-vocal-biomarker-tool-on-zoom-app-marketplace-for-real-time-behavioral-and-cognitive-health-screening 2026-06-23T16:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/wheeler-bio-launches-redesigned-website-showcasing-expanded-integrated-cdmo-capabilities-and-ai-ml-enabled-modularcmctm-platform 2026-06-23T16:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/time-toxicity-in-lymphoma-study-reveals-stark-differences-in-treatment-burden-among-bispecific-antibodies 2026-06-23T16:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/american-lung-association-launches-campaign-to-educate-patients-on-expanded-access-programs-for-investigational-lung-disease-treatments 2026-06-23T16:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/sandboxaq-launches-ai-powered-virtual-screening-platform-that-predicts-gpcr-drug-mechanism-of-action 2026-06-23T15:06:12+00:00 hourly 0.9 https://trial.medpath.com/news/nvidia-launches-bionemo-agent-toolkit-to-bring-agentic-ai-to-life-sciences-r-d 2026-06-23T15:05:49+00:00 hourly 0.9 https://trial.medpath.com/news/oligonucleotide-synthesis-market-to-reach-8-6-billion-by-2035-driven-by-therapeutic-pipeline-expansion-and-crispr-adoption 2026-06-23T15:05:47+00:00 hourly 0.9 https://trial.medpath.com/news/ai-in-healthcare-risks-encoding-and-amplifying-health-inequities-experts-warn 2026-06-23T14:45:00+00:00 hourly 0.9 https://trial.medpath.com/news/joseph-balthasar-pioneer-in-antibody-drug-conjugate-and-protein-therapeutics-research-named-suny-distinguished-professor 2026-06-23T14:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/front-line-chemo-immunotherapy-shows-promise-for-advanced-penile-cancer-in-landmark-phase-2-trial 2026-06-23T14:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/inmune-bio-secures-mhra-approval-of-pediatric-investigation-plan-for-ebstrocel-in-rdeb-clearing-key-regulatory-hurdle 2026-06-23T14:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/daniel-skovronsky-eli-lilly-s-chief-scientific-officer-appointed-to-illumina-s-board-of-directors 2026-06-23T14:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/beyond-the-right-answer-why-medical-ai-agents-need-process-aware-benchmarks 2026-06-23T14:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/cms-proposes-tighter-prior-authorization-timeframes-for-drugs-but-experts-say-fragmentation-and-transparency-gaps-remain 2026-06-23T13:35:00+00:00 hourly 0.9 https://trial.medpath.com/news/draeger-receives-fda-510-k-clearance-for-evita-v800-software-3-10-with-advanced-ards-ventilation-features 2026-06-23T13:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/insmed-appoints-samuele-butera-as-svp-general-manager-global-respiratory-to-lead-brinsupri-launch-and-pipeline-expansion 2026-06-23T13:07:10+00:00 hourly 0.9 https://trial.medpath.com/news/trimtech-therapeutics-secures-14m-extension-bringing-total-seed-round-to-47m-for-targeted-protein-degradation-in-neurodegenerative-disease 2026-06-23T13:07:04+00:00 hourly 0.9 https://trial.medpath.com/news/women-s-clinical-trials-cros-market-to-more-than-double-by-2036-reaching-22-3-billion 2026-06-23T12:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/tissue-free-ctdna-detects-molecular-residual-disease-months-before-tnbc-recurrence 2026-06-23T12:08:29+00:00 hourly 0.9 https://trial.medpath.com/news/mobile-health-clinics-expand-access-to-screenings-and-preventive-care-as-budget-pressures-mount 2026-06-23T12:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/2026-un-high-level-meeting-on-hiv-aids-adopts-bold-political-declaration-reaffirming-2030-goal-to-end-aids-as-a-public-health-threat 2026-06-23T11:06:39+00:00 hourly 0.9 https://trial.medpath.com/news/abu-dhabi-s-department-of-health-and-sanofi-partner-to-establish-ai-enabled-vaccine-innovation-centre 2026-06-23T10:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/inventus-control-a-purpose-built-mobile-device-management-platform-for-clinical-trials 2026-06-23T10:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/florida-issues-emergency-schedule-i-ban-on-ultra-potent-7-oh-kratom-extracts-linked-to-hundreds-of-overdose-deaths 2026-06-23T09:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/multi-omics-and-machine-learning-poised-to-advance-precision-medicine-in-ulcerative-colitis 2026-06-23T07:08:29+00:00 hourly 0.9 https://trial.medpath.com/news/pro-neuropeptide-y-emerges-as-a-circulating-biomarker-for-poor-prognosis-in-prostate-cancer 2026-06-23T07:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/usf-health-recruits-internationally-renowned-physician-scientist-shyam-kottilil-to-lead-clinical-research-expansion 2026-06-23T05:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/wef-names-personalized-mrna-cancer-vaccines-and-exosome-drug-delivery-among-top-10-emerging-technologies-of-2026 2026-06-23T05:06:36+00:00 hourly 0.9 https://trial.medpath.com/news/fecal-calprotectin-shows-predictive-value-for-gi-gvhd-after-allogeneic-stem-cell-transplant 2026-06-23T03:07:26+00:00 hourly 0.9 https://trial.medpath.com/news/ah-008-achieves-dual-regulatory-milestones-with-u-s-fda-ind-clearance-and-taiwan-cde-index-case-designation-for-cipn-prevention 2026-06-23T03:06:49+00:00 hourly 0.9 https://trial.medpath.com/news/california-and-vermont-lead-nationwide-push-to-ban-paraquat-a-pesticide-linked-to-parkinson-s-disease 2026-06-23T02:06:36+00:00 hourly 0.9 https://trial.medpath.com/news/syntax-bio-and-applied-stemcell-forge-strategic-collaboration-to-advance-crispr-based-programmable-stem-cell-therapies 2026-06-23T02:06:32+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-and-fallon-win-cannes-lions-pharma-grand-prix-for-prostate-cancer-screening-campaign 2026-06-23T01:09:18+00:00 hourly 0.9 https://trial.medpath.com/news/canada-invests-892122-in-ai-driven-antimicrobial-peptide-research-to-combat-antibiotic-resistance-in-poultry 2026-06-23T01:09:13+00:00 hourly 0.9 https://trial.medpath.com/news/summer-immersion-program-equips-150-scientists-with-human-based-research-methods-wins-nih-recognition 2026-06-23T00:08:32+00:00 hourly 0.9 https://trial.medpath.com/news/charles-river-laboratories-emerges-as-stronger-2026-pick-amid-pharma-services-restructuring 2026-06-23T00:08:05+00:00 hourly 0.9 https://trial.medpath.com/news/who-declares-bundibugyo-virus-outbreak-a-public-health-emergency-adds-first-diagnostic-test-to-eul 2026-06-23T00:04:00+00:00 hourly 0.9 https://trial.medpath.com/news/hhs-launches-multi-agency-initiative-to-reclaim-u-s-leadership-in-clinical-research 2026-06-22T22:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/industry-and-patient-groups-seek-changes-to-fda-s-revised-master-protocols-guidance 2026-06-22T21:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/ai-powered-tools-aim-to-transform-chronic-pain-management-for-rural-older-adults 2026-06-22T21:08:13+00:00 hourly 0.9 https://trial.medpath.com/news/utah-launches-first-ai-powered-prescription-refill-program-sparking-national-debate-on-medical-ai-regulation 2026-06-22T21:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/lipid-molecule-erucamide-slows-retinal-degeneration-by-activating-myeloid-immune-cells-via-tmem19 2026-06-22T20:09:41+00:00 hourly 0.9 https://trial.medpath.com/news/frontiers-launches-research-topic-on-cellular-dysregulation-in-autoimmune-and-autoinflammatory-diseases-seeking-novel-therapeutic-strategies 2026-06-22T20:09:27+00:00 hourly 0.9 https://trial.medpath.com/news/prp-injections-outperform-corticosteroids-and-nsaids-in-advanced-knee-osteoarthritis 2026-06-22T19:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/caltech-researchers-borrow-bird-derived-r2-retrotransposon-to-engineer-plant-genomes-with-unprecedented-precision 2026-06-22T19:09:41+00:00 hourly 0.9 https://trial.medpath.com/news/how-menopause-radically-reshapes-the-brain-energy-crisis-structural-changes-and-implications-for-alzheimer-s-risk 2026-06-22T19:09:38+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-car-t-cells-offer-one-shot-remission-in-rheumatoid-arthritis-preclinical-study-shows 2026-06-22T19:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/ucla-s-dr-theodore-scott-nowicki-receives-100000-hero-grant-to-advance-armed-car-t-therapy-for-pediatric-osteosarcoma 2026-06-22T19:09:23+00:00 hourly 0.9 https://trial.medpath.com/news/copper-induced-cell-death-activates-immune-system-offering-new-strategy-to-overcome-immunotherapy-resistance 2026-06-22T19:09:07+00:00 hourly 0.9 https://trial.medpath.com/news/keio-university-launches-11th-healthcare-venture-contest-with-focus-on-mibyou-pre-symptomatic-measures-and-entrepreneurial-strategy 2026-06-22T19:08:57+00:00 hourly 0.9 https://trial.medpath.com/news/study-identifies-birthweight-sex-ethnicity-and-paternal-age-as-risk-factors-for-early-onset-colorectal-cancer 2026-06-22T17:56:00+00:00 hourly 0.9 https://trial.medpath.com/news/gut-health-experts-cut-through-the-hype-fiber-fermented-foods-and-food-safety-caution-outrank-probiotic-pills 2026-06-22T17:23:10+00:00 hourly 0.9 https://trial.medpath.com/news/walmart-and-sam-s-club-launch-nationwide-medicare-navigation-initiative-as-glp-1-bridge-program-takes-effect 2026-06-22T17:22:41+00:00 hourly 0.9 https://trial.medpath.com/news/oatmeal-avocado-and-peppermint-oil-emerging-evidence-for-dietary-adjuncts-in-type-2-diabetes-management 2026-06-22T17:22:28+00:00 hourly 0.9 https://trial.medpath.com/news/promising-single-dose-malaria-therapy-spap-advances-toward-pan-african-clinical-trial 2026-06-22T17:22:20+00:00 hourly 0.9 https://trial.medpath.com/news/growth-hormone-therapy-in-children-unanswered-questions-on-musculoskeletal-safety-long-term-outcomes-and-precision-monitoring 2026-06-22T17:22:20+00:00 hourly 0.9 https://trial.medpath.com/news/california-s-life-science-industry-faces-policy-crossroads-as-economic-impact-hits-394-billion 2026-06-22T17:21:20+00:00 hourly 0.9 https://trial.medpath.com/news/massive-open-access-chemistry-database-powers-ai-driven-drug-discovery-and-catalyst-innovation 2026-06-22T17:21:18+00:00 hourly 0.9 https://trial.medpath.com/news/betterlife-pharma-appoints-mahan-chehrenama-do-as-chief-medical-officer-to-lead-betr-001-toward-migraine-ind 2026-06-22T17:20:20+00:00 hourly 0.9 https://trial.medpath.com/news/uwf-researcher-secures-825000-florida-cancer-innovation-grant-to-launch-statewide-lifestyle-intervention-for-breast-and-prostate-cancer-survivors 2026-06-22T17:20:12+00:00 hourly 0.9 https://trial.medpath.com/news/international-patents-granted-for-remedee-labs-endorphin-stimulating-mmwave-wristband-for-chronic-pain 2026-06-22T17:19:52+00:00 hourly 0.9 https://trial.medpath.com/news/new-p-tefb-bhlhe40-tim8-tim13-axis-reveals-hif-independent-hypoxic-gene-regulation-in-treatment-resistant-tumors 2026-06-22T16:06:56+00:00 hourly 0.9 https://trial.medpath.com/news/ipsen-to-acquire-memo-therapeutics-in-deal-worth-over-eur700-million-securing-phase-ii-bk-polyomavirus-antibody-potravitug 2026-06-22T16:06:47+00:00 hourly 0.9 https://trial.medpath.com/news/fda-declines-to-approve-achieve-life-sciences-cytisinicline-for-smoking-cessation-citing-manufacturing-issues-only 2026-06-22T16:06:31+00:00 hourly 0.9 https://trial.medpath.com/news/dea-kicks-off-historic-cannabis-rescheduling-hearing-amid-lawsuits-and-exclusion-controversy 2026-06-22T16:06:30+00:00 hourly 0.9 https://trial.medpath.com/news/china-closing-in-but-us-still-leads-in-biotech-innovation-cure-survey-finds 2026-06-22T16:06:25+00:00 hourly 0.9 https://trial.medpath.com/news/paul-weiss-and-kirkland-steer-abbvie-s-10-9-billion-acquisition-of-apogee-therapeutics 2026-06-22T16:05:52+00:00 hourly 0.9 https://trial.medpath.com/news/nih-sennet-consortium-unveils-first-comprehensive-atlas-of-senescent-cells-introducing-senotypes-framework 2026-06-22T15:47:00+00:00 hourly 0.9 https://trial.medpath.com/news/systemic-immunotherapy-transforms-advanced-cutaneous-squamous-cell-carcinoma-management-mechanistic-insights-guide-agent-selection 2026-06-22T15:07:13+00:00 hourly 0.9 https://trial.medpath.com/news/leerink-partners-strengthens-oncology-research-with-veteran-biotech-analyst-asthika-goonewardene 2026-06-22T15:06:46+00:00 hourly 0.9 https://trial.medpath.com/news/orano-med-leverages-nuclear-fuel-legacy-to-chase-radiopharma-leadership-with-lead-212-therapies 2026-06-22T15:06:44+00:00 hourly 0.9